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Abstract 
 
 
Bioactive compounds are revolutionizing the nutritional and medicinal world with 
their inherent disease-fighting properties. A wide range of functional groups fall under 
the category of imparting health benefits. Compounds from both animal and plant origins 
have been generated as bioactive agents that have opened up new vistas for alternative 
medicine and natural healing.  For example, in a debilitating disease like cancer, these 
compounds can act to suppress or delay the underlying pathology over and above the 
conventional treatment strategies involving drugs or chemotherapy. In other words 
conventional and invasive therapy, although still considered appropriate at certain stages 
of cancer, their low success rates have necessitated and ushered in an era of 
nutraceuticals or naturally available bioactive compounds that can through diet reduce the 
progression of cancers thereby providing a replacement or supplement to pharmacologic 
treatments. As a result many, including Americans are supplementing traditional health 
care by turning to nutraceuticals and functional foods.  
Animal and plant derived bioactive compounds have been shown to render 
positive health benefits. However with the outbreaks of a few meat-related illnesses, 
vegetarianism is on the rise. Compounds derived from plants including fruits and 
vegetables are being researched for the presence of bioactive compounds. Cereal grains 
are also being identified to be valuable sources of bioactive proteins and peptides that 
help arrest disease progression. The increasing knowledge of peptides with anti-disease 
properties like antihypertensive, antimutagenic, and anticancer has created commercial 
interest in using them as functional ingredients in food products. Bioactive peptide 
research had focused primarily on animal, fish, and dairy proteins but owing to disease 
  
 
propensities and religious reasons many are turning to study and recommend plant 
derived products. Protein isolates and fractions from food sources have been shown to 
exert anti-mitogenic, anti-hypertensive, anti-cancerous, and anti-microbial effects, 
particularly peptides that are broken down from proteins available in foods have been 
documented to possess anti-disease characteristics. Hence exploring and testing for 
bioactivities, in compounds originating from plant sources has gained interest. Cereal 
proteins particularly have been utilized to obtain hydrolysates and peptides for testing 
against disease attributes like anti-hypertensive or anti-cancer etc.  
The following research has been based on grounds of utilizing cereal grains’ by-
product and hopes to provide scope for reducing cancerous states with the use of natural, 
inexpensive and readily available value-added byproducts obtained during processing of 
certain cereal grains.  
Rice bran is one such byproduct obtained during milling of rice. It contains 90% 
of the nutrients and nutraceuticals, and forms 8-10% of the total weight. The rice bran 
components include high quality protein, phenolics, dietary fiber, source of vitamins and 
minerals. Rice bran is primarily used as animal feed and to extract oil which is used in 
cooking. It has nearly 20% protein and could be a source of bioactive peptides and hence 
a functional food for health benefits. The State of Arkansas is ranked number one in the 
production of rice and, rice bran is a cheap co-product of rough rice milling. Rice bran 
production rate in the United States has reached 800,000 tons annually. Although rice 
bran production is so high, it is mostly under-utilized.  
In spite of numerous potential health benefits little work has been done with rice 
bran to produce functional bioactive compounds. Rice bran protein has the potential for 
  
 
creating anticancer peptides. The high quality protein can be broken down to generate 
peptides. There are no systematic studies reported on the production of anti-cancer 
peptides from commercially available heat stabilized defatted rice bran by proteolytic 
enzyme hydrolysis and, particularly their resistance to gastrointestinal environment. 
Therefore, a systematic study on the production of gastrointestinal resistant peptides from 
rice bran by enzymatic hydrolysis, and testing for anticancer activity was needed.  
In this research rice bran was used for preparing peptides with an intention of 
providing benefits in controlling cancer cell growth. The protein was directly hydrolyzed 
using food grade enzyme to prepare peptides. These were treated with simulated gastro-
intestinal juice before fractionation and collection according to their molecular sizes 
using ultra-filtration technique. The different sized peptides were tested for bio-activity 
by cell culture techniques to assess their ability to control cancer cell proliferation.  
Identifying and characterizing rice bran peptides that can arrest human cancer cell 
proliferation formed the broad objective of this study. As a summary heat stabilized 
defatted rice bran was treated with endoprotease, alcalase after optimizing conditions for 
enzymatic hydrolysis using response surface design. Degree of hydrolysis (DH) was 
considered as the dictating response variable for enzymatic hydrolysis, which was set at 
nearly 25% to avoid both excessive hydrolysis (over 40% DH) and limited hydrolysis 
(under 15%). The resulting hydrolysates were treated with simulated gastric and intestinal 
juices to obtain gastrointestinal (GI) resistant peptides. The peptides were fractionated 
into molecular size ranges of >50, 10-50, 5-10, and <5 kDa using ultrafiltration. They 
were tested for their abilities to reduce cell viability and cause cytotoxicity to human 
cancer cells in vitro employing the trypan blue dye exclusion assay as well as a cell titer 
  
 
assay that uses a tetrazolium dye [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; (MTS)] and the 
electron coupling reagent, phenazine methosulfate or [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] (MTT).  
In order to provide a comprehensive picture for cancer cell proliferation inhibitory 
effects of the peptide fractions, and also due to the specificity of each cancer cell type, 
cancer cells derived from multiple sites representing colon, breast, lung and liver were 
chosen. The idea was to evaluate rice bran peptide(s) for multiple site activity against 
cancers. Two colon cancer cell lines including a tumorogenic cell line, two breast cancer 
cell lines including a tumorogenic cell line, a lung and a liver cancer cell line were 
selected for the study. The idea of including tumorogenic cell lines representing colon 
and breast was to decipher any probable anti-tumorigenic activity of the bran peptide 
fractions because colon and breast organs are prone to involve tumors as part of cancer 
pathology more commonly than other cancer types chosen for the study. Both GI and 
non-GI resistant fractions were initially screened with each cancer cell line for evaluating 
cell viability patterns of the fractions. Based on the findings the <5kDa fraction exhibited 
better anti-cancer activities followed by the 5-10 kDa fraction compared to other 
fractions, controls as well as non-GI resistant fractions. The <5 kDa fraction was selected 
for further confirmatory anti-cancer properties using relatively more specific assays. 
Dosage and anti-tumorigenic assays were also performed on the <5kDa fraction that 
initially showed better anti-cancer properties. This fraction was selected for 
characterization purposes.  
  
 
The highlight of the research has been the demonstration of GI-resistant <5 and 5-
10kDa bran peptide hydrolysates to inhibit growth of certain cancer cell types more 
effectively compared to controls, and nonresistant fractions. GI resistant fractions had 
better anti-cancer activities than non-GI resistant fractions of which the <5 and 5-10kDa 
fractions served as prime candidates for possessing anti-cancer activities based on initial 
screening. Specifically, the <5kDa fraction showed 70-75% cytotoxicity to colon (Caco-
2, HCT-116), 70-80% cytotoxicity to breast (MCF-7, HTB-22) and 80% cytotoxicity to 
liver (HepG2) cells respectively. The 5-10kDa fraction caused 80% cytotoxicity to liver 
(HepG2) cancer cells alone. This implies that <5kDa fraction is able to arrest cancer cell 
proliferation and could also serve as anti-tumorogenic agent. The <5kDa fraction was 
characterized to obtain a pure peptide that when tested for cancer cell proliferation 
showed nearly 80% inhibition to colon, breast and liver cancer cells. Amino acid analysis 
of the peptide revealed the presence of Arginine, Proline and Glutamic acid residues. Full 
characterization of the peptide by proteomic tools coupled to mass spectrometry enabled 
determination of the amino acid sequence, Gln-Glu-Arg-Pro-Arg. Thus a penta-peptide 
from rice bran has been isolated and characterized for multiple-site activity against 
cancers. This could mean that a food-derived peptide could act as a cheaper natural 
alternative over synthetic anti-cancer drugs for treatment against cancers originating from 
multiple sites.  
The significance of the findings observed in this study lies in the potential 
capacity by which a natural nutraceutical agent like rice bran could bear positive impact 
on human health through its protein components providing potentials for advancement in 
medicinal application from an agricultural standpoint, while it is considered as a co- 
  
 
product of a larger process. Successful utilization of data from this research will 
revolutionize the concept of preparing peptides with bioactivity against human cancers 
and promote further study of value added products from the cereal grains like rice bran.  
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 1 
Introduction 
 
Food proteins and biopeptides have biological functions in addition to their 
established nutritional value as a source of protein (Dziuba et al., 1999). Such bioactive 
peptides are nutraceuticals and functional food ingredients possessing the ability to bring 
health benefits or reduce the risk of diseases like cancer, hypertension, obesity, diabetes 
etc. for human beings, and thus are in large demand by the global market. Numerous 
bioactive peptides have been obtained from enzymatic digestion of food proteins, 
although the types of biological activities of the peptides obtained are different with 
protein source, enzyme specificity, and processing conditions including pH, time and 
temperature (Wang and Gonzalez de Mejia, 2005). With vegetarianism on the rise, and 
high quality nutritional compounds utilized only as animal feed during several 
food/cereal grain processing stages, there is a need for evaluating such compounds for 
bioactivity for application into human health.  The overall objective is thus to utilize 
protein components obtained from rice bran, an abundantly produced co-product during 
rice milling that is both underutilized and inexpensive, as a nutraceutical agent that can 
arrest human cancer cell type’s proliferation. The need for evaluating rice bran for anti-
cancer bioactive peptides is validated by limited information available of rice bran being 
used as a natural functional bioactive agent. Moreover there is an increasing commercial 
interest in the production of economical biopeptides from proteins, particularly from 
cereal grains where bioprocesses otherwise render certain nutritionally rich co-products 
only as feed for animal.  
For obtaining protein or peptide hydrolysates from food sources both chemical 
and enzymatic approaches have been followed. However, it is evident from studies that 
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have attempted to obtain protein isolates from rice bran that, the proteins in bran are 
thought to be complexed with lipids and carbohydrates thereby providing difficulties in 
protein extraction (Tang et al, 2002). Use of both enzymatic and chemical methods has 
been explored wherein extraction of a substantial amount of protein from de-fatted rice 
bran was achieved. Heat stabilization and de-fatting processes with the aid of enzymes 
have been shown to weaken the protein-lipid and protein-carbohydrate interactions 
thereby improving protein extraction yields. Besides, to prepare peptides or protein 
hydrolysates it is preferred to directly access the bran protein instead of preparing protein 
isolates, where the purity and yield could be compromised. Hence direct hydrolysis of 
defatted rice bran would be preferred.  
Since specificity and extent of hydrolysis are important factors that need to be 
controlled to not only obtain peptides on a consistent basis but also improve functional 
properties of food proteins and peptides (Nielson, 1997), the degree of hydrolysis is an 
essential parameter and the suitable response factor in any statistical design used for 
optimizing conditions for enzymatic hydrolysis. Degree of hydrolysis will determine the 
proportion of peptide bonds hydrolysed from rice bran protein. 
For bioavailability from the food product consumed, the peptides need to be 
resistant to gastrointestinal environment. Thus the peptides need to be exposed to the 
gastric/intestinal pH, enzymes and microbial flora present in the gut in order to be 
resistant to the digestive processes. Soluble peptides that are resistant to gastrointestinal 
environment can only render bioactivity more effectively and, can thus extrapolate as 
bioavailable nutraceutical ingredients. The protein hydrolysates or peptides obtained from 
any source need to be exposed or evaluated for gastrointestinal resistance Very few 
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studies have involved gastric and intestinal treatments to food proteins/peptides that have 
implicated bioactivities because it has been implicated that the colonic microflora could 
have an influence to the fate of the peptides. Many of the known bioactive peptides have 
been produced in vitro using gastrointestinal enzymes, usually pepsin and trypsin to 
render them resistant to the gut environment. Angiotensin-1 converting enzyme (ACE)-
inhibitory peptides and Caesino phosphopeptides (CPP), for example, are most 
commonly produced by trypsin. Other digestive enzymes and different enzyme 
combinations of proteinases—including alcalase, chymotrypsin, pancreatin, pepsin and 
thermolysin as well as enzymes from bacterial and fungal sources have also been utilized 
to generate bioactive peptides from various proteins (Haque et al, 2006). 
Human cancers having varied etiologies (genetic and environmental) and high 
cancer mortality rates have surfaced as a top life-threatening condition. Most organs and 
cellular types have been reported to be affected by cancer when there is an imminent 
underlying pathology, with varying degrees. For treatment modalities it is essential to 
identify the cause for each type of cancer. Furthermore the agent in question needs to be 
evaluated for different cancer cell types because of specificity in the mode of action. 
Anti-cancer properties are generally evaluated by observing a reduction in the cancer cell 
viability and/or a possible metabolic arrest in the cancer cells upon addition of the 
compound in question and photometrically quantifying cell survival. While dye exclusion 
assays signify cell viability, dye binding/localization coupled to photometric detection 
can signify cell survival. Most studies have employed the MTT or MTS dye assay as a 
confirmatory assay for determining anti-cancer properties. Several others have used 
tumorogenic cell lines and have conducted clonogenic assays for possible anti-tumor 
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activities too. In this study dye exclusion, binding and clonogenic assays were performed 
to determine anti-cancer properties of rice bran peptide fractions/pure peptide on several 
human cancer cell lines including colon (Caco-2 and HCT-116 cell lines), lung (A-549), 
breast (MCF-7 and HTB-22 cell lines), and liver (HepG-2).  
In order for the anti-cancer bioactive compound to impart bioactivity to its 
maximum potential, it needs to be free of potential interacting substances that may have a 
confounding effect on its activity. As an initial step in characterization of such bioactive 
peptides studies have used membrane fractionation procedures. Several membrane 
separation processes have been used depending upon the molecular size of the desired 
product. Ultrafiltration by far has been the most commonly employed fractionation 
procedure to be applied to food peptides ranging from 1-100kDa. It may be extremely 
useful to have definite molecular size fractions from the protein hydrolysate pool so that 
initial screening for bioactivity can be evaluated for in the fractions. Generating peptide 
fractions with definite molecular cut off membranes have been produced and also 
recommended. Fractionation, typically from higher (50-100 kDa) to lower (1-5 kDa) 
molecular cut off membranes have been used particularly for peptides obtained from food 
sources. In this study use of 50, 10 and 5 kDa will be done for generation of peptide 
fragments in the ranges <5, 5-10, 10-50, >50 kDa before testing for anticancer activities 
in human cancer cell lines thereby easing the characterization processes.  
Purification of the peptide from the protein hydrolysate pool forms a very 
important task. Using powerful proteomic tools with high resolution, peptides can be 
purified from protein hydrolysates. Chromatographic separation methods are commonly 
used to achieve maximum purity. In purifying peptides from the lower molecular size 
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fractions, employing ion-exchange chromatography primarily followed by reversed phase 
chromatography can be the most efficient means of obtaining highly purified peptides 
than either ion exchange or reversed phase chromatographic separation alone. For 
example, a peptide, Lactoferricin was purified using cation-exchange chromatography 
(Dyonisius et al, 1997). while Luffacylin, another peptide was isolated from sponge 
guard seeds and characterized with the help of DEAE-cellulose ion exchange 
chromatography (Parkash et al, 2002). Analytical and preparative HPLC have been used 
in addition to ion exchange chromatography to improve purity and yield of the peptide. 
Specific c-18 peptide columns are designed especially for peptide purification. Multi-step 
processes involving repetitive chromatographic separation may be considered when the 
purity of the peptide is compromised at any stage of separation. The individual peptides 
or combination (two for synergistic activity) may then be evaluated for enhanced 
bioactivities and further characterization can be done to decipher the amino acid contents 
and sequencing. This information can be used to chemically synthesize the anticancer 
peptides for pharmaceutical use or other uses where purity is needed.   
Objectives 
Bioactive peptides are increasingly becoming popular candidates for traditional 
and alternative treatment strategies in disease states where conventional treatment has 
proven cumbersome or expensive. Although there are several food sources (animal and 
plant) to explore for bioactive compounds, cereal grains have gained much attention this 
decade for their sustained production, use and wider acceptance as compared to other 
food derived products with relatively poor sustenance and shelf life. Besides, bioactive 
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peptides incorporated food products are limited in the United States and there is a need 
for these products to reduce the risk of chronic diseases like cancer.  
Heat-stabilized de-fatted rice bran (HDRB) can be a good starting material for 
creating new bioactive peptides, as non-defatted brans from cereals containing 
moderately higher concentrations of protein (oat, wheat, rice, and corn bran 17.0, 15.5, 
13.0, and 8.0% approximate protein, respectively) have been neglected as a source of 
protein due to difficulties in extraction. Although soy protein hydrolysates and peptides 
for instance, have the potential to decrease cancer cell proliferation, availability and cost 
may be important factors for consideration. HDRB may thus qualify as a naturally 
abundant cereal source to prepare bioactive peptides from. The primary objective would 
be to prepare protein hydrolysates and peptides from rice bran by directly using protease 
at optimum degree of hydrolysis. 
Even though bioactive peptides have been studied extensively, their resistances to 
enzymes and microflora in the gastrointestinal tract have not been evaluated. Therefore, a 
systematic study on the production of resistant peptides from HDRB by enzymatic 
hydrolysis is necessary before testing for anticancer bioactivity, which will comprise the 
core section of the study. Finally for enhanced bioactivity full characterization of the 
peptide(s) obtained from the pool of bran hydrolysates needs to be done. The individual 
pure peptides that demonstrate superior anti-cancer activities can be subjected to amino 
acid analysis and sequencing. This information can be used to chemically synthesize the 
anticancer peptides for pharmaceutical use or other uses where purity is needed.   
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This study will provide the basis for developing novel gastrointestinal 
environment resistant bioactive peptides active against different cancer cell types from 
rice bran. The following specific objectives are outlined in the context of this study. 
Specific Objectives 
a. Preparation of peptide hydrolysates from heat stabilized defatted rice bran by 
enzymatic hydrolysis using response surface design optimization. 
b. Preparation of gastrointestinal juices resistant peptide hydrolysates and fractionation 
to generate peptide fractions of definite molecular sizes, >50, 10-50, 5-10 and 
<5kDa. 
c. Determination of anti-proliferative and cytotoxicity activities of peptide fractions on 
      human colon, breast, lung and liver cancer cells. 
d. Purification and characterization from the fraction(s) having promising anti-cancer 
activity and test the purified peptide(s) for anti-cancer activity on cancer cells.  
e. Amino acid analysis, mass spectrometry and sequencing of the purified peptide.  
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Literature Review 
 
Rice production in the United States and Arkansas 
Rice is considered a staple food for a major part of the world.  
The global rough rice production was estimated to reach a new record level of 666 
million tons in 2008 and an increase by manifold compared to previous years (2006: 8.8 
million metric tons; 2007: 9.0 million metric tons). Asian countries like China and India 
top the overall rice production rate, followed by the United States. The United States is 
unique as one of the largest exporters of all rice types, supplying more than 13 percent of 
the rice that enters world trade. Approximately 88 percent of the rice consumed in the 
United States is grown in the United States. U.S. rice is in demand in high quality 
markets around the world (USA Rice federation, 2008). 
Arkansas leads the nation in rice production. Arkansas farmers produce about 80 
million hundredweight (cwt) of rice annually, which is 40 percent of the U.S. crop. The 
farm gate value of Arkansas-grown rice is about $700 million in 2008. The estimated 
economic impact of the rice industry in Arkansas is $2.5 billion. Despite rising prices for 
U.S. rough rice over the next 10 years, plantings are projected to increase 25,000 to 
50,000 acres a year and to remain at 200,000-400,000 acres below the (record) 2005/06 
level (USDA NASS (2008)–Arkansas agricultural Statistics Service). 
Rice bran production 
 
Rice bran forms 8-10% of the total weight of rough rice and contains 
approximately 90% of its nutrients and nutraceuticals. Rice bran is considered the most 
valuable by-product of rough rice produced in abundant quantities in the Arkansas State. 
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However, it is mostly under-utilized. Rice bran production rate in the United States has 
reached 800,000 tons annually of which the State of Arkansas produces over 50% of the 
total production. ((USDA NASS (2007)–Arkansas data). 
Rice components and co-products 
Rice grain is composed of 3 basic components: the hull, a brown bran layer, and 
the kernel (Figure I). The kernel, bran, and hull represent approximately 70, 10, and 20% 
of the weight of rough rice. Milling of rough rice involves several stages (Figure II). 
Milling rough rice initially requires removing the hull, leaving brown rice. White rice is 
then produced by removing the bran layer. The bran layer normally contains 15% fat, and 
rice industries may subject the bran to further processing to extract the oil from the bran, 
producing residual de-fatted rice bran. Co-products of the rice milling industry - hulls, 
rice bran, de-oiled rice bran, and rice mill feeds (a mixture of hulls and bran) - may be an 
economical alternative to grains. Despite the large production of rice and rice co-products 
in the south-central United States, limited research is available on the nutritional value.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from Encyclopedia Brittanica. 1996 
 
Figure I Structure of a rough rice grain 
 
 
 
10 % 70 % 
1 % 
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Figure II. Stages in Rice processing 
 
Rice bran and composition 
Bran is a component of the rice grain and is made up of the pericarp, seed-coat 
and nucleus (Juliano and Bechtel 1985, Juliano 1993) (Figure.I). Rice bran contains 
approximately 10.5- 12.0% water, 18.5-20.9% protein, 1.5-2.0% lipid, 15.3-16.8% starch, 
25.2-25.6% total fiber, 2.0-2.5% total phenolics, 1.73-2.28% phytic acid, and 9.0-10.4% 
ash (Juliano, 1985; Hettiarachchy, 2003) in addition to B vitamins and minerals. Major 
anti-nutritional factors such as phytate, trypsin inhibitor, haemagglutinin-lectin s and 
oryzacystatin are also found within the bran (Juliano 1993).  
Commercially, rice bran is stabilized by heat treatment to prevent deterioration 
resulting from hydrolysis and oxidation of oil. The commercial rice bran product after 
heat treatment and removal of oil (15-20%) is referred to as "heat-stabilized defatted rice 
bran" (HDRB) and is mainly used for animal feed and pet foods. Heat treatment results in 
protein denaturation and aggregation with other components, and lowers protein and 
phytochemical extractability. In addition, rice bran contains B-vitamins and minerals, and 
Rough 
rice 100% 
Hull 20% 
Brown 
rice 80% 
White  rice 70% 
Rice bran 8-10% 
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trace elements. The positive nutritional and nutraceutical attributes of rice bran include 
hypoallergenicity, gluten-free, and a source of dietary fiber. 
Through further processing to extract and market the oil from rice bran, some rice 
milling industries offer de-oiled (defatted) rice bran as a co-product feed. One advantage 
of de-fatted rice bran over raw rice bran is a longer shelf life. Rice bran becomes rancid 
unless it has been stabilized in a manner such as extruding that will destroy the lipase 
enzyme. With the removal of fat, there is an expected reduction in degree of 
esterification. Extracting the oil concentrates the remaining nutrients. Raw rice bran 
contains 12-18% oil, whereas defatted bran contains about 1 to 3 percent oil only. 
Defatted bran contains higher percentage of protein (17-20%), vitamins (A and E) and 
minerals than full fatted bran obtained from raw and parboiled paddy.  
Proteins and amino acids in rice bran  
The bran component of rice grain contains 12-20% protein which includes 
proteins like albumins (37%), globulins (36%), glutelins (22%), and prolamins (5%). 
(Saunders, 1990, Betschart et al, 1977, Hettiarachchy, 2003,). Rice bran proteins are 
difficult to extract. The possible reason may be due to the tight bonding or interaction 
these proteins have with carbohydrate moieties within the rice bran (Hamada, 1995). 
Studies have attempted to extract proteins from rice bran (Wang, et al 1999). Some 
components that interact in such a way to hinder high extractability of proteins include 
fiber (12%), and phytic acid (1.7%) (Juliano, AACC 1994). Heat stabilization is generally 
done to maintain the quality of rice bran oil that results in interaction between proteins 
and carbohydrates, which in turn contributes toward less protein extraction efficiency 
(Tang et al, 2002; Tang et al, 2003). 
 13 
Muksud et al (2000) had studied the amino acid contents of different varieties of 
rice bran. Eighteen amino acids were found in the total form, and thirteen amino acids in 
the free form. Aspartic acid (1.3-1.8%), glutamic acid (0.48-1.7%) and tyrosine (0.97-
1.42%) as total form amino acids and aspartic acid (0.05-0.15%) and threonine (0.098-
0.20%) as free form amino acids were reported to be present in appreciable quantities in 
all the varieties of rice bran. Wang et al (1999) have reported amino acid levels in rice 
bran protein isolate. They found higher amounts of acidic amino acids like glutamic acid 
(125mg/g protein) and aspartic acid (80mg/g protein), while arginine (89mg/g protein) 
and leucine (74mg/g protein) were also found to be predominant.   
Several approaches have been considered to maximize extraction of protein and 
amino acids from rice bran. The amounts of protein and amino acids produced seem to be 
higher in cases where subcritical water hydrolysis method was followed compared to 
conventional alkali hydrolysis (Sereewatthanawu et al, 2007). In general acidic amino 
acids are abundant in rice bran protein prepared, and the manner of hydrolysis dictates 
the nature of peptides and amino acids that could be obtained.  
Rice endosperm proteins: extraction and functionalities 
Rice proteins are considered as competent ingredients because of their recognized 
nutritional, hypoallergenic and healthful qualities suited for human consumption (Eggum 
et al 1992, Fiocchi et al, 2003). Rice proteins are also ranked high in nutritional quality 
compared to other cereals like corn and wheat. Although rice is generally regarded as 
having the lowest protein content (7.3%) among the common cereal grains (wheat 10.6%, 
corn 9.8%, barley 11%) the net protein utilization of rice proteins (73.8%) is the highest 
among the cereal grains (wheat 53%, corn 58%, barley 62%,) (Bean and Nishita, 1985).  
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Much work has been done to assess the physicochemical properties of rice endosperm 
proteins following chemical and enzymatic processes. Physicochemical properties of rice 
endosperm proteins have been studied following chemical and enzymatic processes 
(Paraman et al, 2006). Since the major component of rice endosperm in starch studies 
have used chemical and enzymatic treatments that break down starch and release protein 
effectively. High-protein rice products can be obtained from rice flour by alkali 
extraction followed by precipitation at the isoelectric pH of the protein (Schafer et al, 
2008). Starch-hydrolyzing enzymes such as alpha-amylase, glucoamylase, and 
pullulanase are often used to separate proteins in rice flour by solubilizing and removing 
starch. In addition to starch hydrolyzing enzymes, cellulase and hemicellulase enzymes 
have been used to further increase the protein content in rice protein concentrate. In a 
study by Paraman et al, (2006), alkali and salt treatments for protein extraction from rice 
endosperm resulted in 86.9 and 87.3% proteins while enzymatic methods with Termamyl 
and amylase S extracted 85.8 and 81.0% proteins respectively. Alkali- and salt-extracted 
proteins had higher solubility and emulsifying properties than proteins extracted from 
enzyme treatments. Comparatively, more favorable protein composition, lower surface 
hydrophobicity, higher solubility, and a lower degree of thermal denaturation of alkali- 
and salt-extracted proteins contributed to higher emulsifying and foaming properties than 
those of enzyme-extracted proteins.  
It is relatively easier to extract proteins from rice endosperm with high yield than 
from rice bran because of the presence of a more complex interaction between 
components of protein in rice bran limiting extractability efficiencies. Moreover due to 
increased accessibility to proteins from rice endosperm much work has been focused on 
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preparing proteins from rice endosperm rather than from rice bran although rice bran has 
relatively more protein.   
Protein extraction from rice bran 
Rice proteins, either from rice flour or rice bran are generally extracted using 
physical and or chemical treatments. Several lipases, carbohydrases or proteases are used 
in the extraction process to achieve maximum purity of extracted proteins. 
Characterization and physicochemical properties of rice bran proteins have been studied 
by many scientists. (Yu et al, 2001, Hamada et al, 2000, Tang et al, 2002, Tang et al, 
2003). These studies employed several lipid removing enzymes, endo- and exoproteases 
to extract maximum amount of proteins from rice bran. Functional properties of rice bran 
proteins have also been determined in several studies. Wang et al (1999) studied physical 
properties like hydrophobicity, emulsification, foaming capacity, solubility, and amino 
acid contents. These properties very much dictate the structure, and hence function of 
protein composites obtained from rice bran. Tang et al (2002) have extracted proteins 
from heat-stabilized defatted rice bran. They employed different processes including 
physical and enzymatic treatments to obtain maximum protein yield. Physical processes 
included freeze-thaw cycles, sonication, high-speed blending, and high pressure. 
Enzymatic treatments used amylase, as well as proteases separately or together. They 
were able to get a maximum of 54-57.8% protein following amylase and protease 
treatments with sonication. Their study observed that physical treatments in combination 
with enzymatic treatments improved the protein extractability efficiency. (Tang et al, 
2002).  
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The alkali method for protein extraction from rice bran pioneered by many 
scientists (Cagampang 1966, Lynn 1969, Chen and Houston 1970, Betschart et al, 1977, 
Saunders 1990, Landers 1992, Prakash and Ramanathan 1994, Gnanasambandam and 
Hettiarachchy 1995, Zumbado et al, 1997, Chen 2000) enables high extractability 
especially from non-heat-stabilized rice bran (Betschart et al, 1977, Gnanasambandam 
and Hettiarachchy 1995). The alkaline method uses the principle that proteins can be 
made highly soluble at a very alkaline pH (pH 10 and above), and can then be iso-
electrically precipitated out as a residue that can be solubilized eventually, and dried. 
This method though highly effective in getting most of the protein in a soluble state, 
causes some structural modifications that render the protein to lose their original 
function. (De Groot and Slump 1969). Functional properties like foaming, emulsification, 
and film formation are also affected during the alkali treatment method. (Kinsella, 1981). 
Given the complexity in preparing protein isolates from rice bran in any form, 
scientists are considering direct utilization of the proteins instead of preparing isolates 
where the desired end products are either protein hydrolysates or peptides for functional 
ingredient benefits. 
Protein hydrolysates and peptides from rice bran proteins 
Research has focused on using hydrolysis as a means to obtain better efficiency in 
protein extraction from rice bran. Furthermore mild hydrolysis of the intact proteins 
present within rice bran could aid in not only releasing the proteins from bran but also in 
preparing protein hydrolysates and peptides for several functional properties. 
Bandyopadhyay et al (2008) prepared protein isolate from full fat rice bran by alkaline 
hydrolysis and isoelectric precipitation; obtained peptides from partial hydrolysis with 
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papain under controlled conditions and studied functional properties. From an industrial 
perspective utility to proteins or partially hydrolysed protein components from rice bran, 
hydrolyzed protein has been produced and exploited as vegetable protein (Jarunrattanasri 
et al, 2007).  
Functional attributes can be destined by the nature of peptides obtained. For 
example, certain antioxidative peptide hydrolysates were generated following enzymatic 
hydrolysis and varied degree of hydrolysis, and it was noted that the hydrolysates that 
had lesser than 10% DH had exhibited more antioxidative properties (Abayomi et al, 
2008). Such studies call for optimization to obtain peptides desirable for specific 
functionalities. With limited literature information about rice bran protein hydrolysates 
and peptides exhibiting functional properties, more research is needed particularly to 
evaluate potential nutraceutical attributes of rice bran peptides like its ability to arrest 
major disease progression states.  
From these studies and also with the inherent complexity of proteins within rice 
bran it is thought that mild and controlled enzymatic hydrolysis is best suited over 
chemical hydrolysis (acid or alkaline) for generation of protein hydrolysates and peptides 
without compromising on functional properties. On the other hand for non-commercial 
purposes of using rice bran protein isolates, and where purity or yield is not important, 
protein isolates can be prepared following chemical means (alkaline extraction). 
Bioactivity of rice bran 
Rice bran obtained from certain pigmented rice seeds for instance has been 
proven to be anti-proliferative, anti-mutagenic as well as anti-oxidative (Nam et al, 
2005). These characters are derived mainly from the phenolics, and other carbohydrate 
constituents. Such food products can readily be recommended to patients or subjects that 
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are predisposed to debilitating diseases like cancer. Rice bran’s bioactivities have also 
been documented from a study that investigated whole rice bran extracts on chemical and 
cell assays. The investigators extracted rice bran from two blackish-purple pigmented 
(Sanhaehyanghyulla and Suwon 415) and one nonpigmented (Chuchung) brown rice 
cultivars. The peptides were able to scavenge superoxide anions, hydroxyl radicals, 
inhibit chemical induced mutagenesis, and also inhibit phorbol-ester induced tumor 
formation in mammalian cancer cell line (HL-60). The extracts from pigmented rice had 
a much higher activity than the non-pigmented rice. The authors recommend use of bran 
obtained from such pigmented rice (seeds) as a source of functional food bearing anti-
disease characteristics.  
Oryzatensin, an ileum-contracting bioactive peptide obtained from rice albumin 
was shown to have a sequence of amino acids Gly-Tyr-Pro-Met-Tyr-Pro-Leu-Pro-Arg. 
This peptide was shown to have immunostimulatory role that was mediated by histamine 
release. There has since been no other study to test rice or rice bran peptides for 
bioactivity. However peptides derived from other food proteins that have been evaluated 
for bioactivities serve as examples for evaluating cereal proteins and peptides as potential 
nutraceuticals in health and disease.  
Gastrointestinal resistance 
For bioavailability and for human consumption, peptides or hydrolysates derived 
from food sources and possessing bioactivities need to be resistant to physical (pH), 
proteolytic (enzymes) and microbial (microbial flora present in the gut) degradation. 
Soluble peptides that are resistant to gastrointestinal environment can thus render 
bioactivity more effectively than non-resistant peptides, and can thus extrapolate as 
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bioavailable nutraceutical ingredients. Bioactive peptides that impact bodily function are 
generally inactive within their parent protein, but exert specific function upon hydrolysis 
of the parent protein. Gastrointestinal (GI) enzymes help to release the peptides, and even 
a fraction of the compound is sufficient to exert the specific function for normal 
physiology.  
There are three phases of assimilation for dietary proteins, a) initiation of 
proteolysis in the stomach by enzymes like pepsin and highly efficient endo- and 
carboxy-terminal cleavage in the upper small intestine cavity (duodenum) by secreted 
pancreatic proteases and carboxypeptidases; b) further processing of the resulting 
oligopeptide fragments by exo- and endopeptidases anchored in the brush-border surface 
membrane of the upper small intestinal epithelium (jejunum); and c) final facilitated 
transport of the resulting amino acids, di- and tripeptides, across the epithelial cells into 
the lamina propria. The nutrients from lamina propria enter capillaries for distribution 
throughout the body (Hausch et al, 2002). Enzymatic hydrolysis by most proteases and 
peptidases do not actively hydrolyze substituted and conformationally constrained amide 
bond of proline residues, and hence might lead to abundance of proline residues in 
gliadins and related proteins from wheat, rye, and barley (Schuppan et al, 2000). This, in 
turn, would lead to an increased concentration of relatively stable gluten-derived 
oligopeptides in the gut, some of which would be expected to cross the intestinal barrier 
to gain access to the subepithelial lymphocytes. 
There have been relatively few studies examining bioactive potentials of peptides 
to evaluate the gastrointestinal resistances of the peptides. The complexity of the human 
gut has provided a predicament to enable selection of parameters (physical), proteolytic 
 20 
(enzymes) and microbial (microbial flora present in the gut) for evaluation of 
gastrointestinal resistance. Ideally animal models closely representing human gut are 
most suited for determining gastric and intestinal digestive resistances of compounds. 
Hausch et al (2002) studied the ability of certain gliadin peptides to resist intestinal 
digestion using pancreatic protease digestion and determining the fate of the peptide. 
Such and several other studies have used in vitro simulatory proteolytic digestion as 
primary presumptive models for conducting gastrointestinal evaluation of compounds.  
 
Generation of bioactive peptides from food 
The methods for studying bioactive peptides are varied, although many rely on in 
vitro methods for demonstrating biological activity. Generation and identification of 
bioactive peptides have been performed in a number of ways. Bioactive peptides are 
inactive within the parent molecule until released by enzymatic hydrolysis, generally via 
the digestive process (either in vivo or in vitro) or by food processing effects. Once 
released, the bioactive peptides are capable of influencing a range of behavioral, 
gastrointestinal, hormonal, immunological, neurological, physiological, vasoregulatory, 
and nutritional responses. 
 
Peptides derived from proteins by physical or chemical processing 
Technologies involving food processing such as using heat, pH changes, or the 
ability of microbial enzymes to hydrolyze proteins, e.g., during fermentation can be 
utilized for generation of biopeptides. Addition of functional groups to peptides to 
promote functionality as chemical modification have also been in practice ever since the 
first kind of casein-derived peptides were phosphorylated, like the 
 21 
caseinophosphopeptides (Mellander in 1950) for enhanced bone calcification in infants. 
During stages of food processing bioactive peptides have been liberated. For example 
during manufacture of milk products, hydrolysed milk proteins have been liberated. The 
plasmin present within milk can contribute to hydrolyze milk proteins to obtain bioactive 
peptides. Bacterial starter cultures that contain proteases help to break down protein to 
peptides as also seen during fermentation where long oligopeptides can be released upon 
breakdown of caesins. Cheese contains phosphopeptides as natural constituents and 
secondary proteolysis during cheese ripening leads to the formation of bioactive peptides 
that are angiotensin converting enzyme (ACE) –inhibitory (Pihlanto-Leppälä, 2001). 
 
Peptides derived from proteins by enzymatic hydrolysis 
Selection of proteases plays critical roles in liberation of bioactive peptide 
fragments. Pancreatic enzymes preferably pepsin, and trypsin and chymotrypsin have 
been popularly used to obtain peptides from food proteins. ACE-inhibitory peptides have 
most commonly been produced using trypsin. Tryptic, chymotryptic and peptic 
hydrolysis of casein protein has resulted in many short peptides possessing biological 
activities like immunomodulatory, ACE-inhibitory, and anti-oxidative properties. 
(Migliore-Samour et al, 1988, Suetsuna et al, 2000). One of the peptides (Ile-Ile-Ala-Glu-
Lys) isolated by Nagaoka et al (2001) isolated from -lactoglobulin by tryptic hydrolysis 
was found to have hypocholesterolemic action that suppressed absorption of cholesterol 
in Caco-2 cells in vitro. Another peptide (Trp-Leu-Ala-His-Lys) derived from -
lactoglobulin has been shown to possess anti-hypertensive activity resultant of ACE-
inhibition (Pihlanto-Leppala et al, 2000).  
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Pepsin-liberated peptides from lactoferrin were found to disrupt the cell 
membrane for penetration into the cell to cause anti-microbial efffect (Schibli, D.J., and 
Vogel, H.J. (2000)). There is evidence to suggest that lactoferricin is generated by 
digestion of lactoferrin in the human stomach (Kuwata et al, 1998). 
Other proteases like alcalase, alkaline protease and proteinases have also been 
used to obtain bioactive peptides mainly from cereal sources like soybean and wheat 
germ. Such proteases have widely been used to generate peptide hydrolysates on a 
commercial basis. Table I lists bioactive peptides obtained from various food proteins by 
enzymatic hydrolysis and their bioactivities. 
 
Advantages of enzymatic hydrolysis over physical processing for generation of 
bioactive peptides 
 Generation of bioactive peptides during physical treatments involved in food 
processing stages can also cause structural and chemical changes with potential 
detrimental effects to the proteins and bioactive peptides. Such effects can prevent their 
release due to the formation of hydrolysis-resistant covalent bonds. Meisel et al (2003) 
has shown effects of dephosphorylation to be attributed to subsequent loss of bioactivity 
like mineral binding capacity. 
Food processing can also damage proteins to such an extent as to render the 
bioactive peptides either inactive following digestion or prevent them from being 
released from the parent protein. Damaged proteins are frequently digested in a different 
manner, as resistant peptide bonds can be generated from heat and/or alkali treatments. 
Hence, peptides that would not normally occur naturally may be generated (Rutherfurd-
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Markwick et al, 2005). The consequences of food processing on the generation of 
bioactive peptides, therefore, require careful attention. Owing to losses in function, 
potential damaging effects to proteins and generation of inadvertent peptides, treatments 
due to physical food processing is not preferred. On the other hand use of enzymatic 
hydrolysis using digestive enzymes that are specific is preferred over physical processing 
for the generation of bioactive peptides.     
Table I Bioactive peptides and their activities 
Protein Protease Peptide Activity 
Casein Trypsin 
Trypsin-
Chymotrypsin 
Pepsin 
Phe-Phe-Val-Ala-Pro
Val-Glu-Pro-Ile-Pro-Tyr-
Gly-Leu-Phe 
Tyr-Phe-Tyr-Pro-Glu-Leu 
ACE-inhibition
     Immunomodulation 
Antioxidative 
-lactoglobulin Trypsin Ile-Pro-Ala-Val-Pke-Lys-
Trp-Leu-Ala-His-Lys-Ala-
Leu-Pro-Met-His-Ile-Arg 
Bactericidal 
ACE-inhibition 
Rice albumin Trypsin Gly-Tyr-Pro-Met-Tyr-Pro-
Leu-Pro-Arg 
Ileum contraction
Immunostimulation 
Soybean Proteinase S
Alcalase 
Leu-Leu-Pro-His-His
Low molecular weight 
peptides 
Antioxidative 
Antihypertensive 
Wheat germ Alkaline protease Ile-Val-Tyr ACE-inhibition 
Antihypertensive 
Genetically 
modified soy 
protein 
Trypsin and 
Chymotrypsin 
Arg-Pro-Leu-Lys-Pro-Trp Antihypertensive
Adapted from Korhonen et al, 2003. 
 
Separation of food proteins/peptides 
Proteins and hence, their constituent amino acids are present abundantly in many food 
sources. Isolation and identification of proteins or peptides of interest for bioactive 
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functional roles is thus a very important step. However characterization has proven to be 
a challenging task because many proteins/peptides can possess closely related 
physicochemical properties (Pouliot et al, 2006).  
The separation of bioactive peptides from enzymatic hydrolysates provides scope to 
create functional foods that can slow disease progressions. Proper analytical separation 
and purification techniques can alone identify specific amino acid sequences, and hence 
peptides as important biological modulators. A number of separation techniques are 
available.  Fractionation and purification techniques are normally performed based on 
where and for what purpose the final product/molecule is rendered applicable. Achieving 
purity generally requires the use of expensive methods such as liquid and gas 
chromatography particularly for industrial applications. As a first step in characterization, 
even before bioactivity can be determined, the generated peptide hydrolysates, say from a 
food source after extraction are normally subject to at least one of several membrane 
filtration procedures to fractionate the peptides into molecular sizes for ease of 
identification of bioactive fractions, and also for further characterization.  
Membrane-separation processes  
A range of filtration material is being used to fractionate molecules based on the 
membrane pore sizes. Choice of the appropriate filtration system depends on the type of 
product needed to be fractionated. For example, an ultrafiltration membrane typically 
consisting of pore sizes between 1-500 nm is used to fractionate proteins and peptides 
from a protein hydrolysate. Nanofiltration materials are used to separate smaller 
molecules like amino acids and salts based on size and charge. They usually operate with 
membranes of pore sizes between 0.1-1 nm. These filtration methods and some others 
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must operate under a consistent pressure ranging from 0.1 up to 50 bars. The following 
table (II) lists the comparative features of membrane filtration methods (Pouliot et al, 
2006). 
 
Table II. Membrane filtration methods 
 Microfiltration 
(MF) 
Ultrafiltration 
(UF) 
Nanoflitration 
(NF) 
Reverse 
osmosis  
(RO) 
Pore size > 0.1 m 1-500 nm 0.1-1 nm < 0.1 nm
Seiving 
mechanism 
Size Size, charge Size, charge Size
Separation 
products 
Particles, globules 
(> 01m) 
Proteins/peptides 
(1-300Kda) 
Amino acids, 
salts, solutes 
Monovalent 
ions( K, Cl) 
Operating 
pressure 
0.1-2 bars 1-10 bars 15-30 bars 30-50 bars
Adapted from Pouliot et al, 2006. 
 
The membranes are normally made up of polymers and bear configurations of hollow 
fibers, flat sheets, tubules or spiral windings. Owing to the subtle differences in 
physicochemical properties among mixture of peptides, a fractionation process such as 
UF or NF is usually preferred over other conventional separation methods. A scheme 
typical for production of peptides using fractionation methods is presented in figure III. 
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Production of peptides using membrane filtration methods 
Enzymatic hydrolysate or fermentation broth 
         Pre-treatments 
Membrane separation (MF, UF, NF) 
                                          Non-hydrolyzed proteins,  
                                                   enzymes, bacteria 
    Peptide mixture 
 
Membrane separation (UF, NF) 
 
                                   Retentate                                              Permeate 
 
 
Bioactive peptides 
 
Purification 
 
Figure III. Production of peptides using 
fractionation methods 
(Adapted from Pouliot et al, 2006) 
 
To cite examples of using membrane filtration methods, Turgeon and Gauthier 
used hollow fiber polysulfone ultrafiltration (UF) membranes having molecular weight 
cutoffs of 30kDa and 1kDa. They were able to obtain a pool of polypeptides that 
improved overall composition compared to the ratio of commercially available whey 
protein concentrate to higher protein content. They also obtained peptides lower than 
5,000 Da, which could be used as emulsifiers in food industry (Turgeon and Gauthier, 
1990). Nau et al (1995) used nanofiltration (NF) process to fractionate -casein peptides. 
With 0.1 to 1nm pore size ranges Nau et al showed separation based on both electric 
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charges and size exclusion. Kimura and Tamano (1986) used charged ultrafiltration 
membranes to separate amino acids between 75 and 200 kDa. Separation of complex 
mixture of 15 amino acids using two membranes with molecular cut-offs 500 Da and 
1,000 Da respectively was studied by Garem et al (1998). It was observed that separation 
with the high-molecular weight cut off (MWCO) membrane was pH dependent, and that 
maximum selectivity was obtained at pH 10 with a low ionic strength. Garem et al also 
used NF membranes to fractionate -casein peptides into acidic and basic peptides at pH 
8.0. 
Soy protein hydrolysates were fractionated using ultrafiltration membranes where 
the effect of membrane pore sizes on the molecular size distribution as well as functional 
properties of the protein hydrolysate were studied (Deeslie and Cherian, 2006). 
Ultrafiltration has also been used to obtain bioactive peptides from soy for ACE-1 
inhibitory activity (Cha and Park, 2005). β-lactoglobulin from whey was isolated using 
ultrafiltration membrane enzymic reactor where the authors were able to retain β-
lactoglobulin in the reactor while peptides generated from hydrolysis of α-lactalbumin 
and serum albumin permeated through the membrane (Sannier et al, 2000).  
 
Purification of food proteins/peptides                 
Liquid chromatography happens to be the most widely used method for analytic 
as well as preparative separations of food derived proteins and peptides. Coupling the 
chromatographic system to conventional UV and fluorescence detectors enables detection 
of proteins and peptides of interest. Furthermore, structural characterization of purified 
proteins and peptides can be achieved by methods such as amino acid analysis, mass 
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spectrometry, SDS–electrophoresis. The recent advent of ionization techniques, starting 
in 1981 with the introduction of fast atom bombardment (FAB), followed by electrospray 
ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI) has made such 
analyses by mass spectrometry possible for proteins and peptides, with (0.01%) high 
accuracy. The latter two methods have become important tools for the detection and 
characterization of large biomolecules, because of their sensitivity, high mass range, and 
the capacity of isolating from complex mixtures. In addition, mass spectrometry (MS) 
analysis can be extended to include interfaces for MALDI source to enable precise 
structural information and characterize and even locate events such as post-translational 
modifications. 
Several preparative chromatographic methods have been used to purify proteins 
and peptides from a complex mixture. Ion-exchange chromatography, hydrophobic 
interaction chromatography, affinity chromatography and size exclusion chromatography 
are the most commonly used chromatographic techniques. These are generally employed 
as initial separation steps where the peptides of interest are isolated out from a given pool 
that had exhibited bioactivity as a whole fraction. Following this, reverse phase HPLC 
has been widely employed with or without coupling to ion-exchange chromatography for 
efficient purification of the peptide of interest (Le´onil et al, 2000) 
 
Ion-exchange chromatography 
Cationic and anionic exchangers (resins) are used to separate molecules based on 
charge. The retention of the molecule in the matrix (column) depends on the intrinsic 
charge and also the induced electrostatic interactions. For proteins and peptides the pI 
(isoelectric point) is the important property for matrix retention. Several proteins and 
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peptides have been subjected to ion exchange chromatography for effective purification. 
Lactoferricin, a peptide from the protein Lactoferrin was separated with high purity using 
cation-exchange chromatography (Dyonisius et al, 1997). Another peptide, Luffacylin 
was isolated from sponge guard seeds and characterized with the help of DEAE-cellulose 
ion exchange chromatography (Parkash et al, 2002). First the seed extract was passed 
through DEAE-cellulose column, and then through a CM-sepharose column and finally 
purified to homogeneity with a FPLC column. The following profile depicts the elution 
profile of the guard peptide through a CM-sepharose column. 
 
 
Figure IV. CM-sepharose elution profile of guard 
peptide with increasing NaCl concentrations. 
(Adapted from Parkash et al, 2002). 
 
Size exclusion chromatography (SEC) 
SEC can be used to separate relatively large peptides, as the gel matrix is not 
suited for small peptides of <1kDa. The matrix consists of a gel of a specific pore size 
through which molecules may pass or get retained on the column owing to their 
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molecular sizes. In general, smaller molecules diffuse faster and better into pores than 
larger molecules, resulting in differential retention times. Prakash et al (2002) prepared 
protein hydrolysates prepared from rice bran employing size exclusion chromatography 
coupled with HPLC. The molecular fragments ranged between 1 and 150kDa after 
hydrolysis with alcalase and flavourzyme. Further, anion exchange chromatography of 
extracted rice bran hydrolysates was performed. Comparison between both alcalase and 
flavourzyme treatments for de-amidation showed on the chromatogram that the protein 
hydrolysates treated with flavourzyme had a longer retention time suggesting the 
occurrence of more negative charges due to de-amidation. The SEC as well as anion 
exchange chromatograms are presented (Figures IV and V).                                                 
 
 
 
 
 
 
 
 
 
Figure V. SEC-HPLC elution profile of rice bran hydrolysates 
treated with enzymes. 
Adapted from Parkash et al, 2002 
 
For certain proteins and bacteriocins a combination of chromatographic 
techniques was used for efficient recovery. Stoffels et al (1993) had developed a two-step 
process of chromatographic separation, first based on adsorption onto hydrophobic 
interaction chromatography resin, and second on a cation-exchange resin. Stoffels et al 
used this two-way process for 100% recovery of nisin. In another similar study by Uteng 
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et al, (2002) bacteriocins were initially bound onto sepharose cation-exchanger resins and 
eluted with NaCl followed by a reverse phase HPLC process with application of low 
pressure. Thus they were able to obtain 90% pure fraction of bacteriocins. 
Characterization of proteins and peptides can thus be performed using several 
chromatographic methods or in combination. Efficient purification generally requires 
manifold optimization trials and hence proves a challenging task. However sophisticated 
instrumentation and automation aids in faster and less cumbersome protein recoveries. 
 
RP-HPLC for purification of bioactive peptides from food 
HPLC/RP-HPLC has replaced classical methods as techniques for separation and 
purification of peptides. Recovery of biological activity is good with most low molecular 
weight peptides. Nowadays the most popular column material is reversed phase, in which 
separation is achieved through partition and through adsorption by unprotected silanol 
groups. In reversed-phase chromatography, the stationary phase is non-polar (or less polar 
than in the mobile phase) and the analytes are retained until eluted with a sufficiently polar 
solvent or solvent mixture (in the case of a mobile-phase gradient). Large peptides (>4,000 
Da) are generally analyzed with reverse phase columns having particles with greater pore 
diameter (300A) so that the molecules will have greater access to the alkyl chains. On the 
other hand smaller molecular pore sizes (60-100A) are preferred for separation of smaller 
peptides. The physicochemical characteristics of peptides greatly influence the choice of 
stationary phase, for example C4 chains are suited for hydrophobic peptides while C8 chains 
are preferred for hydrophilic or relatively lesser hydrophobic peptides. The most widely used 
organic modifier for separation for peptides has been acetonitrile due to its high transparency 
in UV detection at around 200-220 nm. Ion-pairing reagents have been used to increase 
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efficiency in separation of peptides. Thus ion-pairing coupled solvents operating in reverse 
phase conditions are proven to yield highly pure peptides.  
The formation of opioid peptides by in vitro proteolysis of bovine hemoglobin by pepsin 
was investigated by RP-HPLC and subsequent off-line identification of collected fractions by 
FAB-MS (Piot et al, 1992) The same technique was used to isolate opioid peptide from milk 
fermented with a strain of Lactobacillus helveticus and to identify some bioactive peptides 
released by pepsin and trypsin digestion of UHT milk fermented by Lactobacillus casei. 
Using RP-HPLC off-line with ESI-MS allowed Dionysius and Milne (1997) to identify 
peptides with antimicrobial activity in tryptic hydrolysate of bovine lactoferrin. Working 
with the same protein, Shimazaki et al (1998) identified a heparin binding peptide after 
pepsin hydrolysis, RP-HPLC separation and MALDI-TOF-MS measurements. RP-HPLC–
ESI-MS was also reported to be useful to monitor the kinetics of a bioactive production 
during continuous hydrolysis of β-casein with chymosin in a membrane reactor.  (Leonil et 
al, 2000). 
The following table (III) illustrates the types of HPLC used for separation of food 
peptides, their separation mechanism and characteristics of separation. 
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Table III. HPLC methods involved with food 
peptides 
HPLC type Separation mechanism Characteristics 
RP-HPLC Hydrophobic interaction of the 
peptides with the stationary 
phase 
High resolution 
High speed 
Standard separation procedures 
Prediction of retention times 
Good detection and 
reproducibility 
Quantitative recovery using 
volatile buffers 
Moderate capacity in analytical 
columns 
IE-HPLC Ionic interaction of peptides 
with anion exchangers or 
cation exchangers as stationary 
phase 
Moderate resolution 
High speed 
High capacity 
Prefractionation of peptides by 
charge 
Wide range of pH 
SE-HPLC Size exclusion of peptides on 
hydrophilic polymers as 
stationary phase 
Moderate or low resolution
High speed 
Very high capacity 
Desalting 
Good prefractionation by size 
Molecular weight 
determination 
Presence of nonspecific 
interactions 
 
Adapted from Handbook of Food Analysis by Leo M. L. Nollet 
 
Amino acid analysis 
Amino acids are released and destroyed at different rates that depend upon the amino acid 
composition and characteristics of the proteins in the sample. In order to precisely determine 
the composition of amino acids present in a protein sample, it is most often necessary to 
hydrolyze the proteins to amino acids. Specifically acid hydrolysis followed by performic 
acid oxidation for cysteic acid and methionine sulphone, and an alkaline hydrolysis for 
tryptophan determination is carried out. A major problem of amino acid analysis in 
foodstuffs is the destruction of amino acids during acid hydrolysis. Unfortunately, this 
problem can be greatest with the essential amino acids likely to be limiting in practical diets: 
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methionine, cystine, lysine, threonine, and tryptophan. Proteins and protein foodstuffs differ 
so widely in their composition that specific hydrolytic procedures would need to be carried 
out for each material.  
For detection of amino acids and quantification chromatographic techniques including 
HPLC and Gas-liquid chromatography are in practice. Pre-column derivatization is required 
for amino acid analysis. Dansyl chloride (5-dimethylamino-1-naphthalene sulphonyl 
chloride) is frequently used for this purpose, producing fluorescent dansyl derivatives that are 
separated by a reversed phase column chromatographic procedure. It has been demonstrated 
that separation particularly of peptides by ion exchange chromatography is more effective 
when followed with HPLC that uses various non-polar stationary phases, for separation of 
non-polar amino acid derivatives (Molnar and Horvath, 1977). 
 
Characterization using proteomic tools 
With the advent of modern tools that aid in precise and quick identification and 
detection of structural components within a complex as well as pure mixture, characterization 
protocols have been made simpler, quicker and reliable. Proteomic tools have been 
developed keeping in mind several factors involved in characterizing a compound for purity 
and to retain functionality. Chromatographic separations are being coupled to spectrometers 
in tandem to enhance separation as well as mass determining capabilities at the same time. 
Such features allow not only decreasing time but also provide increased sensitivities. Of the 
several tools available, the most popular and increasingly diverse especially with proteins is 
the mass spectrometer and its accessory coupling instruments available for characterization 
studies.  
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Mass spectrometry  
Mass spectrometry (MS) is an analytical technique for the determination of the 
elemental composition of a sample or molecule. It is also used for elucidating the chemical 
structures of molecules, such as peptides and other chemical compounds. The MS principle 
consists of ionizing chemical compounds to generate charged molecules or molecule 
fragments and measurement of their mass-to-charge ratios (David, 2000). In a typical MS 
procedure, a sample is loaded onto the MS instrument, and its compounds are ionized by 
different methods (e.g., by impacting them with an electron beam), resulting in the formation 
of charged particles (ions). The mass-to-charge ratio of the particles is then calculated from 
the motion of the ions as they transit through electromagnetic fields. 
The two primary methods for ionization of whole proteins are electrospray ionization 
(ESI) and matrix-assisted laser desorption/ionization (MALDI). MALDI deals well with 
thermolabile, non-volatile organic compounds especially those of high molecular mass and is 
used successfully in biochemical areas for the analysis of proteins, peptides, glycoproteins, 
oligosaccharides, and oligonucleotides (Hillenkamp, 1991). It is relatively straightforward to 
use and reasonably tolerant to buffers and other additives. The mass accuracy depends on the 
type and performance of the analyzer of the mass spectrometer, but most modern instruments 
should be capable of measuring masses to within 0.01% of the molecular mass of the sample, 
at least up to 40,000 Da. Two approaches are used for characterizing proteins.  In the first 
approach, intact proteins are ionized by ESI or MALDI, and then introduced into a mass 
analyzer. In the second, proteins are enzymatically digested into smaller peptides using 
proteases such as trypsin or pepsin, either in solution or in gel after electrophoretic 
separation. Other proteolytic agents are also used. The collection of peptide products are then 
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introduced to the mass analyzer. When the characteristic pattern of peptides is used for the 
identification of the protein the method is called peptide mass fingerprinting (PMF), if the 
identification is performed using the sequence data determined in tandem MS-MS analysis it 
is called de novo sequencing.  
MALDI is based on the bombardment of sample molecules with a laser light to bring 
about sample ionisation. The sample is pre-mixed with a highly absorbing matrix compound 
for the most consistent and reliable results and a low concentration of sample to matrix works 
best. The matrix transforms the laser energy into excitation energy for the sample, which 
leads to sputtering of analyte and matrix ions from the surface of the mixture. In this way 
energy transfer is efficient and also the analyte molecules are spared excessive direct energy 
that may otherwise cause decomposition.  
Tandem mass spectrometry (MS-MS) is used to produce structural information about a 
compound by fragmenting specific sample ions inside the mass spectrometer and identifying 
the resulting fragment ions. This information can then be pieced together to generate 
structural information regarding the intact molecule. Tandem mass spectrometry also enables 
specific compounds to be detected in complex mixtures on account of their specific and 
characteristic fragmentation patterns.  
Peptides fragment in a reasonably well-documented manner. The protonated molecules 
fragment along the peptide backbone and also show some side-chain fragmentation with 
certain instruments. There are three different types of bonds that can fragment along the 
amino acid backbone: the NH-CH, CH-CO, and CO-NH bonds. Each bond breakage gives 
rise to two species, one neutral and the other one charged, and only the charged species is 
monitored by the mass spectrometer. The charge can stay on either of the two fragments 
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depending on the chemistry and relative proton affinity of the two species. The most 
common cleavage sites are at the CO-NH bonds which give rise to the “b” and/or the “y" 
ions. The mass difference between two adjacent “b” ions, or “y" ions, is indicative of a 
particular amino acid residue.  
 
Amino acid sequencing 
N-terminal amino acid sequence of proteins and peptides helps in determining the correct 
sequence and number of amino acids that constitute proteins/peptides. Proteins can thus be 
probed for the occurrences of functional di- or tri-peptides within their structures to identify 
critical areas that impart significant functional characteristics to the protein. The findings can 
also provide exact amino acid composition of functional peptides to pharma chemists who 
could perform chemical in vitro synthesis of the same. Invariably N-terminal amino acid 
sequencing by the dideoxy method is the standard method of choice, and has been employed 
in several studies involving peptides. Low molecular weight peptides on alcalase treatment of 
soybean proteins have been isolated and identified to be effective against hypertension. 
Similarly a sequence of nine amino acids obtained from hydrolysis of rice albumin protein 
was found to promote immunostimulation. Several peptides ranging in amino acids of about 
5-10 have been successfully isolated and proven beneficial against disease characteristics 
(Table I). 
Caseinomacropeptide (CMP), the C-terminal moiety of κ-casein, i.e., residues 106–169, 
cleaved by chymosin during cheese making, is known to be a mixture of highly 
heterogeneous glycomacropeptides. CMP was reported to have diverse nutritional and 
biological significances due to its unique amino acid composition and sialic acid content. In 
particular, since CMP does not contain the aromatic amino acid residues, several reports 
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suggested the use of CMP as a protein source for the treatment of phenylketonurea, a 
hereditary disorder in which aromatic amino acids cannot be metabolized (Leonil et al, 
2000). 
Peptides derived from canola protein hydrolysate that inhibited ACE-1 activity when 
purified and analyzed for amino acids showed that the gel permeation chromatography 
fraction contained 45% content of aromatic amino acids in comparison to 8.5% of the 
hydrolysate. Two peptides, Val-Ser-Val and Phe-Leu were purified (Wu et al, 2008). 
The activity of biofunctional peptides is based on their inherent amino acid composition 
and sequence. The size of active sequences may vary from two to twenty amino acid 
residues, and many peptides are known to have multifunctional properties (Meisel and 
FitzGerald, 2003) e.g., peptides from the sequence 60-70 of ß-casein show 
immunostimulatory, opioid and angiotensin I converting enzyme (ACE)-inhibitory activities. 
This sequence has been defined as a strategic zone (Migliore-Samour and Jolles, 1988; 
Meisel, 1998). The sequence is protected from proteolysis because of its high hydrophobicity 
and the presence of proline residues. Other examples of the multifunctionality of milk-
derived peptides include the αs1-casein fraction 194-199 showing immunomodulatory and 
ACE-inhibitory activity, the opioid peptides α- and ß-lactorphin also exhibiting ACE-
inhibitory activity and the calcium-binding phosphopeptides (CPPs), which possess 
immunomodulatory properties (Korhonen and Pihlanto, 2003). 
Precise sequence information can help peptides to be synthesized in vitro, and also in large 
scale where the finished product can be suitable for ingredient formulation functioning as a 
nutraceutical agent. 
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Determination of anti-cancer activities and mode of action 
Typically, evaluation of growth inhibitory patterns, cell survival and proliferative indexes 
fall under the battery of screening tests for compounds predicted to have some bioactivity 
against cancerous states or cancer cell proliferation. Dye exclusion assays are indicators for 
cell survival while metabolic (cytotoxic) assays are more specific and prognostic in nature. 
Usually a combination of quantifiable (cell survival) and mechanistic (cytotoxicity) assays 
are recommended to arrive at a possible mode of action for the anti-cancer substances 
(Masters, 2000). On the other hand a few assays have been developed solely for the purpose 
of oncology research. One such is the clonogenic assay which relies also on the effectiveness 
of an agent on the cancer cell survival and proliferation indexes and differs in that clones of 
cells that are capable of forming tumors are used rather than non-tumorigenic cancer cells. It 
finds application especially in research laboratories to determine effects of drugs or radiation 
on proliferating tumor cells (Franken et al, 2006). 
Human Cancers and natural anti-cancer compounds 
 
Colon cancer  
Colon cancer or colorectal cancer is the second leading cause of cancer-related mortality 
in the United States (American cancer society, 2008). Over the past decade, the incidence of 
colorectal cancer has not decreased, and hence no improvements in the mortality rates. 
Studies have shown that after the age of 50, men are more vulnerable to colorectal cancer 
than women (American cancer society, 2008).  
Etiology of colon cancer 
Most of the colon cancers develop as a polyp – a tissue growth into the center of the 
colon or the rectum. The type of polyp that normally tends to becomes cancerous is called the 
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adenoma. Ninety five percent of colorectal cancers are adenocarcinomas (American cancer 
society, 2008).  
There is evidence that dietary components are considered as one of the most important 
environmental factors in the cause of the colorectal cancer. A number of studies, both clinical 
and epidemiological thus tend to provide clues that these food compounds may act as suitable 
markers or dietary determinants that when modified and prepared in a bio-functional form 
can serve as bioactive compounds in reducing the incidence of colorectal cancers. Food and 
food compounds that have been identified as those that promote high incidence of colorectal 
cancers include animal fat, red meats, chocolate, alcohol and refined cereals in Western 
societies whereas fruits, vegetables, fiber, whole grains and their compounds like folate and 
calcium have been identified as protective agents against not only colorectal but also other 
cancers (Levi et al, 1999). Although genetic factors are associated with the etiology of the 
disease and that they predispose individuals to colorectal cancer, much of this predisposition 
appears to be related to differences in dietary habits.  
Bioactive agents against colon cancer 
A number of in vitro studies suggest that proteins may be protective against colorectal 
and many other cancers. For example the whey protein has been proven to reduce the 
incidence of tumor formation in rats that were chemically induced to have colon cancer 
(Hakkak et al, 2001). The same study compared the effect of casein protein as diet to that of 
whey protein in decreasing the tumor formation, and found that casein did not prove as 
effective in reducing the tumor formation. Also whey proteins have been shown to protect 
more effectively than red meat against chemically induced formation of aberrant crypt foci 
 41 
that are considered as markers for colon cancer, first detected in rodents (Bird RP, 1987) and 
later in Wistar rats (Belobrajdic et al, 2003).  
Other proteins investigated for anti-carcinogenic properties of the colon include alpha-
lactalbumin. This study demonstrated that at low concentrations of the protein alpha-
lactalbumin (10-25 ug/mL) cell growth during the first 3 to 4 days was stimulated. After 4 
days, cell proliferation had ceased with low viable cell counts suggesting probably a delayed 
apoptotic behavior (Sternhagen et al, 2001). In another study dietary intake of soy protein 
was shown to decrease tumor incidence in rat models of chemically induced colon cancer 
(Xiao et al, 2008), by inhibiting DNA damage and cell survival of colon epithelial cells 
through attenuated expression of fatty acid synthase. Animal models, usually for colon 
tumorigenesis, show that whey protein is superior to other dietary proteins for suppression of 
tumor development Whey protein components like β-lactoglobulin, α-lactalbumin and serum 
albumin have also been studied to effect anti-tumorigenic potential against colon cancer 
(Parodi, 2007). 
Use of proteomics in colon cancer  
Proteomics has greatly aided in the study of mechanisms of actions of several food 
components. Some of them include psychoactive compounds present in grape seed extract 
(Kim et al, 2006), and anti-microbial peptides from cheese extracts (Losito et al, 2006). 
Molecular targets that these dietary components act upon have been elucidated using the 
colon cancer cells as a model with the help of proteomic techniques. Employing techniques 
like the 2-dimensional gel electrophoresis, Mass spectrometry, and tryptic or proteolytic 
digests of proteins, biological actions of compounds like quercetin on the growth of cancer 
cells was studied to the level of the proteome within the cell (Davis and Hord, 2005). It was 
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also found from the same study that quercetin altered the expression of 20 proteins at least 2-
fold, and the proteins included several heat shock proteins and annexins. These proteins play 
significant roles in the physiology of apoptosis, metabolism, and gene regulation (Wenzel  et 
al, 2004). 
Irrespective of the compound studied, a clear understanding of the mechanism of anti-
cancerous or anti-proliferative effects can be visualized by studying the patterns of protein 
expression inside the cell that is subjected to study. That way proteomics proves useful.  
Food and food components against colon cancer 
Proteins and peptides have been shown to affect anti-proliferative effects on colon cancer 
cells, and these have been confirmed with animal studies. Predominantly flavones and 
isoflavones have been shown to possess anti-proliferative/anti-cancer effects on colon cancer 
cell lines. Cereals like rice or rice bran for example, has proteins, and other important 
components that inhibit cancerous cell proliferation. Tricin for example, present in rice bran 
is a flavone that is shown to cease colon cancer cell proliferation. Further it inhibits 
cycloxygenase activity, reduced prostaglandin production and thus interferes in intestinal 
carcinogenesis in mice (Cai et al, 2005). Certain chemopreventive phenols obtained from 
brown rice were shown to inhibit growth of both colon and breast cancer cells. Most of the 
functions that rice bran elicits are attributed to its non-protein components.  
There is so far, no literature information on rice bran proteins/peptides that have anti-
cancerous effects, or other bioactive functions. Such studies with rice and their components 
only seem to emphasize that the incidence of both colon and breast cancer are much lower in 
Asian countries where rice is a staple diet.  
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Breast cancer  
Most breast cancers develop in the ducts (ductal carcinoma), some in the lobules 
(lobular carcinoma), and the rest in other tissues. Initially lumps form due to fibrocystic 
changes accompanied with scar-like tissue formation, swelling and pain. Gradually they 
become invasive. The most common form of breast cancer is the infiltrating (invasive) ductal 
carcinoma. This develops in the duct, penetrates the duct wall, and invades the fatty tissue of 
the breast. From there it can spread to any part of the body. This type of breast cancer 
accounts for about 80% of invasive breast cancers (American cancer society, 2006). 
Breast cancer, the most common cancer among women is also the second leading 
cause of cancer death among women, next to lung cancer. Current statistics point out that 
there are slightly over 2 million women living in the United States who have been treated for 
breast cancer (American cancer society, 2008). 
Chemoprevention by the use of drugs, vitamins, or other compounds to reduce the 
risk of developing cancer has gained considerable attention to block or suppress malignant 
transformations or disease progressions. Many food products are found to contain 
compounds and proteins that aid in alleviating the disease progression in many cancer states 
by preventing cancerous cell proliferation. If modified and administered properly these can 
replace expensive drugs or other invasive treatment modalities of cancer.  
Food and food components against breast cancer 
Fruits and vegetables are considered good sources of anti-cancerous/anti-proliferative 
agents (Hocman G, 1989). For instance, the genus Brassica that contains cruciferous 
vegetables like broccoli, and cauliflower are known to have certain carbohydrate moieties 
called the glucosinolates that when hydrolyzed cause reversal of chemically induced 
carcinogenesis (Verhoeven  et al, 1997).  
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Several mechanisms have been hypothesized to understand the mechanism of action 
of these compounds in mitigating breast cancer. Some of them include apoptosis, arresting 
cell cycle progression, and also interfering with metablosim. Mammalian breast cancer cell 
lines investigated with the juices of Brassica family displayed anti-proliferative effects 
suggesting the presence of substances within the vegetables that are able to prevent cancer 
progression (Brandi et al, 2005).  
Other than compounds having carbohydrate moieties, proteins are also considered 
good agents to reduce cancer progression. Most important and widely studied is the soy 
protein isolates. As such soy compounds render cancerous cell proliferation arrest, and added 
to this the protein isolates and hydrolysates are becoming effective against cancer 
progression too. In a study that tested the effect of soy protein isolates with breast cancer, 
colon cancer and also prostate cancer researchers found that the protein isolates reduced the 
incidences of chemically induced colon as well as mammary gland tumors in mice (Badger et 
al, 2005).  
Cereals like rice, and rice bran contain compounds that can prevent cancerous cell 
proliferation. Tricin, a flavone extracted from rice bran has been shown to arrest breast 
cancer cell growth even at submicromolar concentrations. Although Tricin at this stage is not 
considered a chemopreventive agent for breast cancer, its accumulation in the gastrointestinal 
tract after consumption tends to reduce the risk of colorectal carcinogenesis propitious (Cai et 
al, 2004). Among cereals, rice is known to contain phenols that interfere with the progression 
of cancers particularly, the colon and breast cancer. Bran extracts constituting major 
phenolics when treated with mammalian breast and colon cancer cell lines reduced the cancer 
cell viability. Based on the results it has been suggested to consume bran rice rather than 
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milled white rice because of the presence of abundant phenolics in the former (Hudson et al, 
2000).  
Role of proteins and peptides in breast cancer 
The RGD (Arg-Gly-Asp) peptide sequence is a common site for proteins in blood and 
the extracellular matrix to bind to and be able to exert biological functions. It has been shown 
to bind to tumor cells and interfere with cancer cell cycle progression. Peptides designed to 
possess this particular sequence when tested for their abilities to arrest cancerous cell growth 
exhibited positive characters. They inhibited tumor growth formation in a dose-dependent 
manner and also induced apoptosis and G1 phase cell cycle arrest in breast cancer cell lines 
(Yang et al, 2006).  
Plant proteins are also found to interfere with breast cancer cell progression states. A 
novel protein, calcaelin isolated from the mushroom Calvatia caelata was found to reduce 
the cell viability of breast cancer cells (Ng et al, 2003).  
Many proteins express differentially between healthy and cancerous cells. Studies 
have attempted to identify certain proteins that serve as markers for cancerous states, so that 
their expression levels can be monitored to study the disease progression (Roberts et al, 
2004). Some of them include estrogen receptor-alpha, beta-caesin, bax, and cytokeratin 7. 
There is so far, no literature information on rice bran proteins/peptides that have anti-
breast cancerous effects, or other bioactive functions. 
 
Lung cancer 
Most lung cancers develop along the lining of the bronchi, and with time, cause pre-
cancerous changes within the lung. When true cancer develops there is formation of 
 46 
chemicals required for the development of new blood vessels which in turn allow tumor 
formation. Once lung cancer cells form, they break away and spread to other tissues 
(metastasis). Eighty five percent of all lung cancers are of the non-small cell type. Other 
classifications include squamous cell carcinoma, adenocarcinoma, and large-cell 
undifferentiated carcinoma (American cancer society, 2006). 
Lung cancer is the number one cause of cancer deaths in the United States. In the year 
2006, The American Cancer Society had predicted approximately 174,470 new cases of lung 
cancer (both small cell and non-small cell). 
Food and lung cancer 
Numerous studies and research have documented the positive links between food, food 
components and lung cancer. Fruits and vegetables are primary food sources that possess 
properties that fight against lung cancer. Since smoking is the chief cause of lung cancer the 
etiology of the formation of lung cancer, needs to be understood clearly in this context in 
order to provide appropriate treatment modalities. It has been shown that smoking causes 
oxidative stress, by generating many free radicals (Chow, 1993). This calls for researchers 
working in the field of nutrition and cancer to look for food sources or food components that 
possess anti-oxidant properties that can possibly counter the cancerous effect or slow down 
the disease progression.  
 
Food and food components against lung cancer 
Cumestrans are chemical compounds present in green vegetables like beans, peas, 
spinach, and sprouts. They have been shown to suppress lung cancer disease states. Studies 
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have also found association between consumption of large quantities of fish and a decreased 
rate of lung cancer (Takezaki et al, 2001). 
Most isoflavones are common anticancer agents in reducing the rate of lung cancer. 
These isoflavones are present in a wide variety of food products including soybeans, yams 
and chickpeas.  
Some plant seeds exhibit anti-proliferative properties, evident from a study that 
investigated the effects of methanolic extract of adlay seed on human lung cancer cell line. It 
was shown that the extract suppressed COX-2 expression via inhibition of gene transcription 
enabling anti-cancerous effect on human lung cancer cell line (Hung et al, 2003). 
Role of proteins in lung cancer 
Proteins are also found to exert similar anti-cancerous and apoptotic roles. In a study, 
milk treatment onto transformed cell lines resulted in an apoptotic picture. The protein 
responsible was identified as a multimeric form of alpha-lactalbumin. This effect was first 
observed in human lung cancer cell line (A549). Cell viability was almost completely 
reduced (98%), and the cells exhibited characteristic features of apoptosis. Other cell lines 
the same protein affected were a variety of epithelial cell lines (Caco-2, HT-29, NCI) kidney 
cell lines (Vero, GMK) and mouse cell lines (WEHI 164, B9). (Hakansson et al, 1995). 
Animal studies conducted to determine the effects of feeding protein rich diets as against 
electrolyte or dextrose/amino acid diets observed that progression of pulmonary metastatic 
disease was reduced, and so did the tumor weight when fed with protein rich diets (casein) 
(Mahaffey  et al, 1987). 
There is so far, no literature information on rice bran proteins/peptides that have anti-lung 
cancerous effects, or other bioactive functions. 
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Several technological options in the literature available are on the production, 
preparation, gastrointestinal resistance evaluation, identification of specific bioactivities, and 
separation and purification strategies for food derived peptides. Depending upon the nature 
of the bioactivity and the target site it is critical to consider all the options available before 
conditions can be established for the production of bioactive peptides. With such an 
understanding peptides derived from rice bran have been prepared and evaluated for anti-
cancer activity. In the following chapters the ways adopted for preparation and 
characterization of anti-cancer rice bran peptides have been documented.  
 
Table IV  List of proteins/peptides having anti-cancer 
effects 
Type of cancer Anti-cancer agent Source Reference 
Prostate Proteins Soy Bylund et al, 2000
    
Breast Protein Soy Badger et al, 2005
 Peptides with RGD 
sequence 
 Yang et al 
 Calcaelin protein Mushroom 
Calvatia caelata 
Ng et al, 2003 
 
    
Lung Alpha-lactalbumin Milk Hakansson et al, 1995
 Casein and other 
proteins 
Animal Mahaffey et al, 1985
Leukemia Ribosomal inactivating 
proteins 
Seeds of Abrus 
precatorius 
Hideki et al, 2004
 Lfcin-B peptide Lactoferrin-B 
protein 
Yoo et al, 1997 
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CHAPTER 1 
 
Human Colon Cancer Cell Proliferation Inhibition By Peptide Hydrolysates 
Derived From Heat Stabilized De-fatted Rice Bran 
Kannan A, Hettiarachchy N, Johnson MG, Nannapaneni R. 
 
      [Part of the chapter published in J Agric Food Chem 2008 Dec 24;56(24):11643-7] 
 
Abstract 
 
Rice bran, an economical, underutilized co-product of rough rice milling, was used to 
produce peptide hydrolysates, which were investigated for anticancer activity against 
colon cancer cells. Protein hydrolysates prepared by Alcalase hydrolysis under response 
surface design-optimized conditions were treated further to obtain gastrointestinal (GI)-
resistant peptide hydrolysates. They were fractionated into >50, 10−50, 5−10, and <5 
kDa sizes and evaluated for inhibitory activity on proliferation of human colon (Caco-2 
and HCT-116) cancer cell lines by Trypan blue dye exclusion assay and confirmed by the 
MTS cell titer and the clonogenic assays. GI-resistant <5 and 5−10 kDa sized peptide 
fractions inhibited growth of Caco-2 cells by 80% compared to controls and non-resistant 
fractions. Anti-proliferative effects were confirmed by the MTS assay wherein 70% 
cytotoxicity to Caco-2 cells and 75% toxicity to HCT-116 cells were observed. The 5-10 
kDa fraction caused 50% cytotoxicity to Caco-2 cells and nearly 60% HCT-116 cells. 
Dosage and anti-tumorigenic inhibitory effects of <5kDa fraction on HCT-116 cells 
revealed that after 72h, 650 µg/mL caused growth inhibition by 80%, signifying high 
dosage and longer time needed for the <5kDa fraction to show anti-cancer effects. From 
the clonogenic assay IC50 dose of the <5 kDa fraction was calculated to be 770 µg/mL. 
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These results indicate that <5 kDa peptide fraction of the rice-bran has a potent anti-
tumor activity for colon cancer cells. 
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Introduction 
Cereal grains and their components are widely investigated for the presence of 
bioactive components. Bioactive components possess the ability to impart health benefits 
or reduce the risk of diseases (Dziuba,et al 1999).  
In the United States cancer is the second leading cause of death. The Centers for 
Disease Control and Prevention (CDC) has estimated nearly 1.4 million new cases of 
cancer in 2008 and half a million deaths due to cancer occurred in 2007 (Cancer statistic, 
2008, American Cancer Society). Colorectal cancer is the second leading cause of cancer- 
related death in the United States. Over the past decade, the incidence of colorectal 
cancer has not decreased, and hence no improvements in the mortality rates. Treatment 
and preventive options for colorectal cancer mainly focus on early detection. There is 
evidence that dietary components are considered as one of the most important 
environmental factors in the cause of the colorectal cancer and hence may act as suitable 
markers or dietary determinants that when modified and prepared in a bio-functional 
form can serve as bioactive compounds in reducing the incidence of colorectal cancers.  
Bioactive peptides comprising 2 to 9 amino acids typically possess specific amino 
acid sequences comprising mainly hydrophobic groups in addition to proline, arginine or 
lysine (Kitts et al, 2003; Korhonen et al, 2003; Dzuiba et al, 1999). Several bioactive 
peptides (Dzuiba et al, 1999, Li et al, 2001; Parkash et al, 2002; Gauthier et al 2003; 
Algaron et al, 2004, Murakami et al, 2004, Quiros et al 2005) have demonstrated 
antioxidant, antiobesity, antiangiogenic, antihypertensive activities, hypocholesterolemic 
and immunomodulatory effects. Peptides and proteins from food sources have aided in 
cancer prevention and treatment. For example, whey proteins and alpha-lactalbumin have 
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been shown to inhibit colon cell proliferation (Sternhagen et al, 2001). Cereal grains 
including soybean, rice, and wheat and their components have been investigated for the 
presence of bioactive proteins and peptides (Yoshinori, 2006). For example, Oryzatensin, 
an ileum-contracting bioactive peptide obtained from rice albumin was shown to have an 
immunostimulatory role (Takahashi, et al 1996). Similarly, proteolytic hydrolysis of 
soybean protein using Alcalase and Proteinase S enzymes resulted in peptides that were 
anti-hypertensive and anti-oxidative respectively (Korhonen, 2003). Rice and its 
components have also been studied to exert specific anti-disease properties like 
antioxidative, anticarcinogenic and antimutagenic (Nam, 2005). However constituents 
like proteins and peptides from rice or co-products of rice milling have been studied to a 
limited extent to be able to confer anti-disease characteristics.  
Rice bran is a cheap co-product of rough rice milling having nutrients including B 
vitamins, minerals and fiber (Juliano, 1985), including oil, which has health benefits 
(Sugano et al, 1997). I t is being used as a low-cost animal feed and the State of Arkansas 
constitutes over 50% of the overall rice production in the country (NASS, USDA 2007). 
De-fatting the bran and directly hydrolyzing the high-quality protein using endoprotease 
can sustainably release peptides in a consistent manner explained earlier. The proteins in 
rice bran are complexed within carbohydrates and lipids and hence provide difficulties in 
protein extraction. Hence, direct hydrolysis of heat stabilized defatted rice bran (HDRB) 
was done to obtain high-quality and high-yield peptides for determining anti-cancer 
activities. This approach was not only unique but also can prove to be an economical way 
of producing anti-cancer peptides from rice bran on a large scale. 
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The objectives were to generate peptides from rice bran by specific food-grade 
enzymatic hydrolysis, generate gastrointestinal resistant peptides, fractionate them to 
obtain definite molecular sized peptide fractions, and evaluate for anti-cancer activities 
on human colon cancer cells. 
 
Materials and Methods 
Materials. Heat stabilized de-fatted rice bran was obtained from Riceland foods 
(Stuttgart, AR), Romicon ultrafiltration system used for fractionation (Koch membrane 
systems, USA), Food-grade Alcalase enzyme was purchased from a bacterial strain 
(Novozyme, USA). Human colon cancer cells including Caco-2 and HCT-116 cell lines 
were purchased from ATCC (Virginia, USA). Dulbecco’s modified Eagles’s medium, 
fetal bovine serum, gentamycin were obtained from Hyclone (USA), MTS kit from 
Promega (USA), MTT kit and McCoy’s SA medium from ATCC (Virginia, USA). All 
other chemicals were purchased from Sigma (MO, USA). 
 
Methods.  
Response Surface optimization for enzymatic hydrolysis of HDRB.  
A Response Surface Model (RSM) was designed to determine the optimum conditions 
for enzymatic hydrolysis of rice bran by food-grade Alcalase enzyme. A four by four 
factorial design was used to evaluate the effect of enzyme concentration, pH, temperature 
and time of incubation for digestion (Table 1.1). The concentration of the substrate, in 
this case being HDRB, was kept constant in the factorial design while other parameters 
like enzyme concentration, pH, temperature and time were varied. Degree of hydrolysis 
was treated as the response variable.  
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Sample preparation. HDRB was ground and passed through a 60 mesh sieve. It was 
stored at 4 ºC until further use. For extraction of protein hydrolysates, the sample was 
allowed to attain ambient temperature overnight. Then, the sample was mixed and 
homogenized with deionized water (1:8 w/v) and stirred for 30 min at ambient 
temperature (Wang et al, 1999). Samples from the mixture were used for RSM 
optimization of enzymatic hydrolysis to prepare protein hydrolysates. 
 
Degree of hydrolysis. The amount of released alpha-amino groups can be measured by 
using reagents that react specifically with amino groups, yielding compounds that can be 
detected spectrophotometrically. Degree of hydrolysis was determined by the ortho-
pthaldialdehyde (OPA) method (Nielson, 2001). Serine was used as the standard in the 
OPA method. The sample solution was prepared by dissolving 0.1g of freeze dried 
protein hydrolysate obtained after RSM optimization experiment in 10 mL deionized 
water. Serine standard/sample solution (400 µL) was added to the test tube (time 0) 
containing 3 mL OPA reagents, mixed for 5 s, let stand  for exactly 2 min and the 
absorbance read at 340 nm in the spectrophotometer.  
Degree of hydrolysis was calculated as follows: DH = h / htot * 100 % 
Where, h  is the number of cleaved peptide bonds, htot is the total number of peptide 
bonds per protein calculated as htot = (serine-NH2 - 0.4)  
Serine-NH2 is the meqv serine NH2 per g protein, 
Serine-NH2 = (ODsample – ODblank) *  0.9516 meqv/L * (sample volume in liter) * 100/ (sample wt in g * Protein %) 
                           (ODstandard – ODblank)  
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Preparation of protein hydrolysates using optimized enzymatic hydrolysis 
parameters 
After determining the degree of hydrolysis by the OPA method on the hydrolysate 
samples obtained during the RSM optimization experiment, parameters were selected 
corresponding to a median value of degree of hydrolysis. A median value was selected to 
ensure that the enzymatic hydrolysis was neither maximum nor minimum. Following the 
optimized conditions, protein hydrolysates were prepared from HDRB (prepared as 
described previously). In order to arrest proteolytic digestion after enzymatic hydrolysis 
the enzyme was inactivated by incubating the reaction mixture at 85 C for 10 min (Novo 
Indistri, 1988). The mixture was then centrifuged at 3,000 g for 15 min to obtain soluble 
hydrolysates in the supernatant. Protein contents of the hydrolysates were analyzed 
before and after hydrolysis following inactivation of the enzyme to ensure no residual 
hydrolysis. 
 
Treatment of HDRB protein hydrolysate with simulated gastric juice. Simulated 
gastric juice was prepared as follows: To deionized water (90 mL) in a 100 mL 
volumetric flask Sodium chloride (0.2 g) and concentrated hydrochloric acid (0.7 mL) 
were added and stirred for 30 min. The final volume was made up to 100 mL with 
deionized water and transferred into a beaker. The pH was adjusted to 2.0 and 0.32 g 
purified enzyme pepsin (Sigma-Aldrich Corp. St. Louis, MO) was added and stirred. The 
temperature of the solution was maintained at 37 °C. Five grams of freeze dried protein 
hydrolysate obtained from HDRB were dissolved in the simulated gastric juice and 
allowed to incubate at 37 °C with constant shaking. After 120 min, the time suitable for 
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evaluating digestive process in vitro (Takagi et al, 2003), pH was adjusted to 7.2 to 
inactivate the enzyme. The reaction mixture was centrifuged at 3,000 g for 20 min to 
obtain soluble peptide hydrolysates in the supernatant. The resistant supernatant 
hydrolysate was freeze dried and stored at 4°C. 
 
Treatment of gastric juice resistant HDRB peptide hydrolysate to simulated 
intestinal juice.  
Simulated intestinal juice was prepared as follows: To deionized water (90 mL) in a 100 
mL volumetric flask potassium phosphate monobasic (0.68 g) and sodium hydroxide 0.2 
N (7.7 mL) were added and stirred for 30 min. Final volume was made up to 100 mL and 
transferred into a beaker. The pH of the solution was adjusted to 8.0 and the mixture 
maintained at 37 °C. Pancreatin (Sigma-Aldrich Corp. St. Louis, MO) at a final 
concentration of 0.1% (Kiersten et al, 2005) was added and stirred. The simulated gastric 
juice treated hydrolysate (in freeze dried form) was dissolved in the simulated intestinal 
juice and allowed to incubate at 37 °C with constant shaking. After 120 min (Takagi et al, 
2003), enzyme was inactivated by heating at 85 oC for 10 min (Kiersten et al, 2005). The 
reaction mixture was centrifuged at 3,000 g for 20 min to obtain soluble peptide 
hydrolysate in the supernatant. The Gastrointestinal (GI) resistant HDRB peptide 
hydrolysate was stored at 4°C. 
 
Fractionation of GI resistant peptide hydrolysate by ultrafiltration. Fractionation is 
often needed to concentrate bioactivity, and also ease in characterization purposes. From 
the fraction that shows better bioactivity peptides can be characterized. Fractionation was 
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carried out with a Romicon ultrafiltration system (Koch membrane systems, USA) 
equipped with 1" diameter hollow-fiber polysulfone membrane cartridges. The filtered 
soluble gastrointestinal resistant peptide hydrolysate was run through sequential 
ultrafiltration columns with membrane-cartridges having nominal molecular weight cut 
offs (MWCO) of 50,000 Da, 10,000 Da, and 5,000 Da. In each MWCO cartridge, the 
peptide hydrolysate was ultra-filtered at a dilution factor of 5. Immediately after the first 
ultrafiltration, the retentate was dia-filtered twice with two volumes of de-ionized water. 
The permeates of the first (50,000 Da) ultrafiltration (UF) and the second, dia-filtration 
step (DF) were pooled and subjected to the second run through the 10,000 Da and then 
5,000 Da MWCOs, respectively. The resulting retentates from each of the MWCO were 
freeze-dried and stored at 4 0C until use for anti-cancer bioactivity. Only GI-resistant 
peptide hydrolysates were subjected to fractionation. 
 
Human colon cancer cell culture and anti-cancer activity testing.   
Caco-2 was cultured at 37C in DMEM (Dulbecco’s modified eagles medium) in the 
presence of 10% fetal bovine serum, supplemented with 1mM L-glutamine, Sodium 
pyruvate, 1mM Sodium bicarbonate and 50 g/mL gentamycin. HCT-116 cells were 
grown in McCoy's 5a medium supplemented with 10% fetal bovine serum (FBS; 
HyClone, Logan UT) and 100 g/mL of penicillin and streptomycin (GIBCO-BRL). 
After cell growth achieved 70%, cell viability was monitored employing the trypan blue 
dye exclusion assay after peptide treatments. The monolayer was allowed to grow for 2-3 
days at 37°C on 24 well flat bottom plates. 100 µL of rice bran peptide fractions at 1 
mg/mL protein content were added to the cultures. For positive (inhibitory) control 
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genistein at 200 and 400 M in saline and for negative (viability) control saline alone was 
used. Genistein is a known anti-cancer agent able to arrest the cell proliferation of several 
cancer cells in vitro. After 24-48 h of treatments the media was removed, and the cells 
briefly dissociated with 0.1% trypsin-0.53mM ethylene diamine tetra acetic acid (EDTA) 
solution. Following this 0.5% trypan blue dye mixed in growth medium was added on to 
each well. Samples were then aspirated from each well and loaded onto chambers in 
haemocytometer cell and cell counts were taken. This assay reflected the number of 
viable cells that survived after treatment with peptide samples. This assay was done with 
GI and non-GI resistant fractions on Caco-2 cells.  
 
Cell proliferation inhibition was determined using the phenazine methosulfate 3-
(4,5-dimethyl thiazole-2-yl)]-2,5-diphenyl tetrazolium bromide (MTS) or MTT mix-
based cell titer assay. After about 36 h of Caco-2 and HCT-116 cells growth respectively, 
cells were trypsinized, loaded onto a hemocytometer and counted. Approximately 1000 
cells per well were used for growth in 96 well flat bottom plates. The cells were allowed 
to attach and grow for 36 h. After 36 h old media were replaced with fresh media, and 
samples of bran peptide fractions were treated with the cells. After 2-4 h exposure of the 
rice bran peptides to the monolayer, the phenazine methosulfate 3-(4,5-dimethyl thiazole-
2-yl)]-2,5-diphenyl tetrazolium bromide (MTS) mix was added at a final volume of 
20 µL/100 µL medium and then incubated for an additional 60 min under the same 
conditions. The reaction was terminated by adding 10% SDS, and the absorbance of 
formazan measured at 490 nm (24). Positive (inhibitory) and negative (viability) controls 
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were used similarly in the trypan blue dye exclusion assay. All assays were performed in 
triplicate and the results expressed as mean values ± standard error. 
Dosage response of the best fraction that showed anti-cancer properties with both 
the exclusion assay and the titer based assay was done on HCT-116 cells starting from 50 
to 650 µg/mL.  
 
Clonogenic assay. Clonogenic assay is a frequently used cancer research assay that tests 
the efficacy of compounds on proliferating cancer cells [Hoffman et al, 1991]. When it is 
done using tumor cells, the ability of the bioactive compound to inhibit tumor progression 
can be evaluated. To determine the anti-tumorogenic activity of rice-bran peptides, the 
clonogenic cytotoxicity assay was performed. The clonogenic assay was performed using 
the HCT-116 cell line following a published procedure [Balusu et al, 2007]. Cells were 
trypsinized and a single cell suspension was prepared. Cells were plated at a density of 
100 cells per 35 mm well. Cells were treated with different concentrations of the rice-
bran peptide fraction. After 72 h, the medium was replaced with fresh medium. Cells 
were allowed to grow for another 8 days and then stained with 0.025% crystal violet. The 
excess crystal violet was removed with 30% methanol, plates were air dried at room 
temperature, and numbers of colonies were counted. 
Data Analysis. Experimental data were analyzed using JMP 7.0 statistical software with 
the least significant differences between samples being P <0.05. Response surface 
method was used as a model to optimize enzymatic hydrolysis of rice bran using Alcalase 
enzyme. 
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Results and discussion 
 
Enzymatic hydrolysis of rice bran by Alcalase enzyme and protein contents.  
Table 1.1 shows a four factorial Response Surface design optimization with optimum 
degree of hydrolysis as well as degree of hydrolysis as response values were determined. 
The four parameters, enzyme concentrations 1.5, 3.5 and 5.0 Alcalase units (AU)), pHs 
(6.0, 8.0, 10.0), temperatures (40C, 50C, 60C) and incubation times for digestion 
(30min, 60min, 90min) were fitted to generate optimum concentrations of enzyme, pH, 
time and temperature for achieving optimum degree of hydrolysis. The three values for 
each parameter were selected based on the optimum condition for alcalase activity 
observed with a true substrate (Novozymes, 2004), and near optimum values were 
chosen. Box-Behenekehn surface response using the JMP 7.0 statistical software was 
used to evaluate the interactions between parameters to generate optimum values for 
enzymatic hydrolysis. Degree of hydrolysis at 23.4% was considered optimum. 
Digested protein contents (in mg/mL) were obtained for each factorial 
combination. For example at 1.5AU enzyme concentration, at pH 8, at 40 ºC for 60 min 
of digestion the digested protein content was found to be 0.993 mg. The prediction profile 
from the response surface design shown in Figure 1.1 enabled selection of the optimum 
conditions needed for proteolytic digestion. The prediction profile designated 3.5AU 
enzyme concentration at pH 8, at 50 ºC, and a 60 min time of digestion for obtaining the 
optimum value for digested protein content, 1.025 ± 0.36 mg/mL with a DH of 23.4%. 
For consistent production of peptides from rice bran, optimized conditions were used for 
performing enzymatic hydrolysis.  
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Enzymatic hydrolysis has been the main approach to produce bioactive peptides from 
soybean, wheat, corn, rice, barley, buckwheat, and sunflower. Earlier studies from our 
laboratory had been directed towards optimizing the extraction of proteins from rice and 
rice bran using enzymatic and chemical approaches. Tang et al, (2002) had reported 
extraction of a substantial amount of protein from HDRB. The types of biological 
activities of the peptides are different with protein source, enzyme, and processing 
conditions including pH, time and temperature (Wang et al, 2005). In this study HDRB 
was digested with food-grade proteolytic enzyme to obtain peptide hydrolysates. Of the 
several food-grade proteases commercially available, cysteine and serine proteases are 
considered popular candidates for cancer research that not only serve as prognostic 
markers for certain cancers but also impart functions to certain tumor suppressor genes. 
Hence, the food-grade protease, Alcalase a commercially available serine protease that 
prefers uncharged residue’s site for action was chosen. In this particular study an 
endoprotease was used instead of chemical treatments in order to attain specificity and 
also to maintain the bioactivity at its optimal level. 
 
Colon cancer anti-cancer activity evaluation of GI resistant and non-resistant rice 
bran peptide hydrolysate fractions.  
Trypan blue dye exclusion assay was conducted to determine cell viability after treatment 
of cells with peptide fractions. This assay evaluates the number of viable cells that remain 
after exposure of peptides on to Caco-2 cells. Both GI resistant peptides as well as non-
GI resistant peptides were tested on the Caco-2 cells.  
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Figure 1.2 depicts the effect of GI and non-GI resistant peptide fractions on Caco-2 cells. 
On Caco-2 cells GI-resistant peptide fractions of sizes <5 kDa and 5-10 kDa were found 
to significantly inhibit the proliferation of viable cells compared to higher molecular 
weight fractions (>10 kDa and >50 kDa), non-GI resistant fractions and also negative 
control. There is approximately a three-fold reduction in viable cells between GI-resistant 
and non-GI resistant fractions that are below 10,000 Da. Similar patterns of inhibition 
between fractions that are above 10,000 Da were not observed. The positive control used 
was genistein at concentrations of 200 and 400 μM. At these concentrations genistein is 
known to inhibit proliferation of cancer cells effectively. It is an isoflavone that is a 
known anti-cancer agent (Steiner et al, 2008). At 200 μM concentration there were 
20,000 viable cells/mL on Caco-2 cell line that was significantly less than the negative 
control (lacking genistein) that resulted in over 100,000 viable cells/mL. Proteins and 
peptides have been shown to possess anti-proliferative effects (Dzuiba et al, 1999) on 
cancer cells, and these have been confirmed with animal studies (data not shown). 
However there have been very few studies that have tested food proteins/peptides for 
their ability to suppress human cancer cell proliferation. Predominantly flavones and 
isoflavones have been shown to possess anti-proliferative/anti-cancer effects on colon 
cancer cell lines. A study reported inhibitory effects of a casein-derived peptide, β-
Casomorphin-7 on human colonic lymphocytes (Elitsur et al, 1991), and in general 
casein-derived peptides could have the ability to arrest colonic epithelial cell proliferation 
and also induce apoptosis (Ganjam et al, 1997). 
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From experimental data it was found that the resistant fractions were more bioactive than 
the non-resistant fractions. When the peptide fractions were tested for gastrointestinal 
resistance, resistant peptides were generated, which not only meant that they were 
exposed to highly specific enzymatic cleavage rendering them to expose more side chains 
but also may imply their suitability in the digestive tract rendering absorptive and hence 
consumable properties. In our body peptides are usually generated when proteins pass 
through the intestine where gastrointestinal enzymes act and release the peptides before 
absorption. Depending upon the nature of the proteins, peptides and their amino acid 
sequences, these proteins/peptides may exert specific biological functions. Bioactive 
peptides when ingested should pass through the intestinal barrier and be transported to 
the target organs to impart antihypertensive or anticancer activities (Tang et al, 2002). 
Thus we support our experimental observations that gastrointestinal resistant peptide 
fractions (<5 kDa and 5-10 kDa) tend to be exposed imparting more bioactivity by 
effectively inhibiting proliferation of colon cancer cells more than the non-resistant 
fractions. Moreover soluble peptides were only generated in a process of eliminating 
organic or other constituents of rice bran that could possibly interfere with bioactivity. 
We believe although rice bran has organic bioactive components, soluble peptides 
derived from enzymatic hydrolysis of protein hydrolysates can aid in inhibitory action of 
human anti-colon cancer cell proliferation, and can have true biological activity in terms 
of bioavailability and delivery.  
 
In order to confirm the peptide-bioactivity experimental findings, a more specific assay, 
the MTS based titer assay was conducted. Figures 1.3 depicts MTS based cell titer assay 
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results for confirming inhibitory actions of peptide fractions on Caco-2 and HCT-116 
colon cancer cells respectively. This assay reflects cytotoxicity as an indication of early 
damage to cells thereby reducing metabolic (mitochondrial) activity. We find there is 
nearly 70% cytotoxicity to Caco-2 cells and 75% toxicity to HCT-116 cells. The 5-10 
kDa fraction caused 50% cytotoxicity to Caco-2 cells and nearly 60% HCT-116 cells. 
The results of this test confirm that resistant peptide fractions <5 kDa and 5-10 kDa 
inhibit growth of colon cancer cells more effectively than the non-resistant fractions. For 
fractions that were >10 kDa pronounced bioactivity was not observed, probably because 
they are longer in length and hence may have needed more time of proteolytic exposure. 
Typically biopeptides studied so far have ranged in very short sizes comprising only 2-9 
amino acids. Hence, it is not surprising to find less or no activity with peptides longer 
than 10 kDa. Since the trypan blue dye exclusion assay was enumerative of the cell 
viability after peptide treatments showing significant bioactivities with the GI resistant 
fractions, only GI resistant fractions were subjected to the MTS assay.  
 
Dosage and anti-tumorigenic inhibitory effects of <5kDa fraction on HCT-116 cells 
Treatment with rice-bran <5 kDa fraction at 24 and 48 h time-points revealed no 
inhibition in the growth of HCT-116 colon cancer cells compared to the untreated cells, 
whereas at the 72 h time-point there was a dose- and time-dependent inhibition in the 
growth of HCT-116 cells (Figure 1.4). The growth of HCT-116 cells was reduced by 
nearly 80% after the treatment with 650 µg/mL of the <5 kDa fraction at the 72 h time-
point. The dose 650 µg/mL was considered the maximum dose that was preparable and 
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testable with the cancer cell lines because doses higher than 650 µg/mL had lower 
solubility thereby interfering with the anti-cancer activity assay. 
The clonogenic assay also indicates the toxicity of the <5 kDa fraction to HCT-116 cells 
(Figure 1.5). The cytotoxicity of the <5 kDa fraction was pronounced after treating the 
cells with 500 µg/mL and that the IC50 dose of the <5 kDa fraction was 770 µg/mL. 
These results indicate that <5 kDa peptide fraction of the rice-bran has a potent anti-
tumor activity for colon cancer cells. 
 
The time- and concentration-dependent growth inhibition patterns observed with the 
<5kDa peptide fraction on HCT-116 cells reveal that the fraction could have a better and 
positive impact on reducing progression of human colon cancer. Further, the clonogenic 
assay, which also reflects cytotoxicity confirms that a higher dosage and longer time is 
needed for the <5kDa fraction to have strong inhibitory or cytotoxicity effect on the 
growth of especially the tumorigenic colon cancer cells. The dosage and time-dependent 
growth inhibition pattern may imply that the fractions may be slow-acting. Higher doses 
may reduce the time needed for killing the maximum number of cells. 
 
Using a presumptive in vitro model like the cell culture to evaluate the bioactive nature of 
peptides obtained from rice bran by enzymatic hydrolysis, we have documented evidence 
that rice bran peptides has the potential as human anti-tumor bioactive agents. The 
findings reported from this study could form a basis for animal and human trials to 
determine the toxicity and confirmatory nature of these bioactive rice bran peptide 
fractions. Results from this study have also enabled us to perform characterization studies 
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on particularly the <5,000 Da sized peptide fraction, so that pure peptides can be obtained 
for in vitro synthesis and sequencing. Identification and characterization of bioactive 
peptides in the laboratory may generate the possibility of supplementing them into our 
diets for fighting against cancer or other diseases that have high mortality rates. Cereal 
grains are known to possess high quality protein which when consumed may be broken 
down by gastrointestinal enzymes in our body to release bioactive peptides. These could 
be our next generation natural anti-disease agents delivered at low cost and high efficacy. 
The use of bioactive peptides in foods, beverages and supplements is well established in 
Japan and is gaining interest in the US (Starling, 2005).. PeptoPro, muscle cells repairing 
peptide, lactium, antistress bioactive peptide, and C12, blood pressure lowering peptide 
from casein are available in the US market. As a closing remark, so far peptides from 
plant proteins have not been commercialized in the US (Wang et al, 2005) and it would 
bear significance if peptides produced from rice bran can be commercialized to be 
incorporated into foods to fight diseases like cancer. 
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 Enzyme pH Temp °C Time (min) Response
00+- 3.5 8 60 30  
+00+ 5 8 50 90  
+0-0 5 8 40 60  
0000 3.5 8 50 60  
--00 1.5 6 50 60  
0+0- 3.5 10 50 30  
0--0 3.5 6 40 60  
00-- 3.5 8 40 30  
0++0 3.5 10 60 60  
+0+0 5 8 60 60  
+00- 5 8 50 30  
0+-0 3.5 10 40 60  
0+0+ 3.5 10 50 90  
+-00 5 6 50 60  
-+00 1.5 10 50 60  
-0+0 1.5 8 60 60  
-00+ 1.5 8 50 90  
0-0+ 3.5 6 50 90  
00-+ 3.5 8 40 90  
0-+0 3.5 6 60 60  
++00 5 10 50 60  
0-0- 3.5 6 50 30  
0000 3.5 8 50 60  
00++ 3.5 8 60 90  
-0-0 1.5 8 40 60  
-00- 1.5 8 50 30  
0000 3.5 8 50 60  
 
Table 1.1 Response surface optimization pattern for 
enzymatic hydrolysis of HDRB.        
Parameters: Enzyme concentration (1.5, 3.5 and 5.0 AU), pH (6.0, 8.0 and 10.0), time of 
hydrolysis (40min, 50min, and 60min), temperature of hydrolysis (40C, 50C, and 
60C).  
Response: Degree of hydrolysis  
 
 
 
 
Figure 1.1 Box-Behnken RSM 3 points prediction profiler 
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Figure 1.2 Viability of Caco-2 cells after exposure to rice bran 
peptide fractions measured by Trypan blue dye exclusion assay 
 
Values are means trials ± SE. Values not connected by same letters are significantly different (P<0.05),  
Negative (viability control): saline 
Positive (inhibitory control): Genistein (400µg/ml).  
Peptide fractions 1mg/ml 
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Figure 1.3. MTS confirmatory anti-cancer activities 
of rice bran peptide fractions (resistant GI fractions) 
on Caco-2 and HCT-116 cells.  
 
Values are means of two trials ± SE. Values not connected by same letters are significantly different 
(P<0.05).  
MTS - (3-(4,5-dimethylthiazole-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
Negative (viability control): saline 
Positive (inhibitory contro)l: Genistein (400µg/ml)  
Peptide fractions 1mg/ml  
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Figure 1.4. Dosage response for anti-proliferative activity of 
bran peptide <5 kDa fraction with HCT-116 cells. 
 
Values are means of three trials ± SE. Values not connected by same letters are significantly different 
(P<0.05), MTS - (3-(4,5-dimethylthiazole-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium 
Negative (viability control): saline  
Positive (inhibitory control): Genistein (400µg/ml)  
Peptide fractions 1mg/ml  
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Figure 1.5. Clonogenic toxicity dose response of bran 
peptide <5 kDa fraction using HCT-116 cells.  
 
Values plotted are means of trials with standard error bars. IC50 indicates 50% inhibitory concentration effective to 
inhibit cancer cell proliferation 
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CHAPTER 2 
 
 Human Breast anti-cancer properties of peptides obtained from heat stabilized 
defatted rice bran by enzymatic hydrolysis 
Arvind Kannan, Navam Hettiarachchy, Satya Narayan 
 
[Part of the chapter accepted for publication in The Open Bioactive compounds journal] 
 
 
Abstract 
Breast cancers are the leading causes of cancer related deaths and illnesses in the United 
States. There is evidence that modification of dietary factors can significantly have a 
positive effect on reduction in breast cancer progression states. Studies associating 
peptides and protein hydrolysates derived from cereal sources like soy to bear anti-
carcinogenic effects have motivated research on proteins and peptides from rice or co-
products of rice-milling such as the bran. These have not been evaluated for anti-disease 
properties particularly against breast cancer. From earlier study <5kDa and 5-10kDa 
fractions caused significant anti-cancer effects and so these fractions were selected for 
testing against breast cancer cells (MCF-7 and HTB-22).  The fractions when tested 
against breast cancer cells caused reduction in breast cancer cell viability monitored by 
trypan blue dye exclusion assay. MTS cytotoxicity assay confirmed the anti-proliferative 
effects of the fractions by causing 70% inhibition to growth of MCF-7 cells and 
approximately 80% on HTB-22 cells. The 5-10 kDa fraction caused approximately 60% 
cytotoxicity to MCF-7 cells. Time- and dosage-dependent pattern of inhibition of <5kDa 
fraction shows maximum sensitivity to HTB-22 cells at 650 µg/mL at 72h time-point. 
This implies that the 5kDa fraction may be effective in inhibiting breast cancer cells with 
high dosage and long time of exposure.   
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Introduction 
Breast cancers are the most leading causes of cancer related deaths and illnesses in the 
United States. According to the American Cancer Society, 40,480 estimated deaths for 
breast cancer (females) were reported in the year 2008 indicating not much reduction in 
the incidence or mortality rates compared to projected estimates in previous years 
(Cancer facts, American Cancer Society, 2008). With dietary and environmental factors 
playing critical roles in the cause and progression of these cancers (Anand et al, 2008), it 
is necessary to explore natural alternatives that are inexpensive and can be available in 
bulk. 
 
Several food sources including fruits and vegetables, cereal grains and their components 
have been investigated for the presence of bioactive proteins and peptides (Mine et al, 
2006). Mammalian breast cancer cell lines investigated with the juices of Brassica family 
displayed anti-proliferative effects suggesting the presence of substances within the 
vegetables that are able to prevent cancer progression (Brandi et al, 2005).  
 
Of the cereal sources, soy and whey protein hydrolysates have been shown to inhibit 
proliferation of breast cancer cells in vitro. Particularly exposure to soy diets has proven 
to reduce the incidence of breast cancer states. Apart from isoflavones present in soy that 
are anti-cancer agents, protein concentrates, hydrolysates and peptides (lunasin) prepared 
from soy have also been shown to have anti-carcinogenic effects (Chiesa et al, 2008).  
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Cereals like rice and rice bran also contain compounds that can prevent cancerous cell 
proliferation. Tricin, a flavone extracted from rice bran has been shown to arrest breast 
cancer cell growth even at submicromolar concentrations. Although Tricin at this stage is 
not considered a chemopreventive agent for breast cancer, its accumulation in the 
gastrointestinal tract after consumption tends to reduce the risk of colorectal 
carcinogenesis propitious (Cai et al, 2004). Among cereals, rice is known to contain 
phenols that interfere with the progression of cancers particularly, the colon and breast 
cancer. Bran extracts constituting major phenolics when treated with mammalian breast 
and colon cancer cell lines reduced the cancer cell viability. Based on the results it has 
been suggested to consume bran rice rather than milled white rice because of the presence 
of abundant phenolics in the former (Hudson et al, 2000).  
 
Proteins and peptides also are listed as bioactive compounds able to and already 
documented as imparting several physiological functions including antioxidant, anti-
obesity, anti-angiogenic, antihypertensive, hypocholesterolemic and immunomodulatory 
(Li et al, 2001, Parkash et al, 2002; Gauthier et al, 2003; Algaron et al, 2004; Murakami 
et al, 2004; Quiros et al, 2005). Studies associating peptides and protein hydrolysates 
derived from cereal sources like soy to bear anti-carcinogenic effects have motivated 
research on proteins and peptides from rice or co-products of rice-milling such as the 
bran. These have not been evaluated for anti-disease properties particularly against breast 
cancer. 
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Since natural foods and their components may have the ability to serve as modulators of 
anti-tumorigenicity either as separate entities or act in synergism (Hemaiswarya et al, 
2006), identification of such compounds within natural foods or co-products obtained 
during the processing of raw foods has promoted nutraceuticals as inexpensive 
alternatives to expensive therapeutic modalities, especially reducing the risks on those 
genetically predisposed. Furthermore, the combination of one or more compounds in 
drug design has proved clinically synergistic benefits toward the treatment strategies for 
cancer (Lao et al, 2004). These could serve to modify the dietary determinants and hence 
slow down the progression of cancers. 
 
Bioactive compounds chiefly comprise the aromatic alcohols like phenols, acids, and 
several organic compounds and have been shown to contribute to mitigate disease 
pathology in cardiovascular disease and cancer (Kris-Etherton et al, 2002). These 
compounds need to be released or extracted with suitable solvents and procedures during 
particular stages of food processing or separately. Our aim was to utilize a naturally rich 
co-product obtained during the processing of rice. There have been relatively few studies 
that have focused on determining bioactive properties of rice and its components (Nam et 
al, 2005). To stress, constituents like proteins and peptides from rice or co-products of 
rice-milling such as the bran have not been evaluated for anti-disease properties even 
with evidences of peptides and protein hydrolysates from cereals tending to possess anti-
disease characteristics. Hence, we aimed at investigating peptide hydrolysates derived 
from rice-bran, a co-product of rough rice-milling for a possible inhibitory activity 
against human breast cancer cells. 
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Rice-bran is a cheap co-product of rough rice-milling having nutrients including B 
vitamins, minerals and fiber (Juliano, 1985). In previous studies, it has been shown that 
whole rice-bran extracts possess anti-proliferative, anti-mutagenic as well as anti-
oxidative properties (Nam et al, 2005). Such studies on identifying specific components 
that could possibly contribute to anti-disease characteristics within rice-bran protein 
isolates or peptides are very minimal. Thus, the objectives of our study were to prepare 
peptide hydrolysates from rice-bran using a food-grade proteolytic enzyme, conduct 
gastrointestinal (GI) treatment to the hydrolysates and fractionate the GI-resistant peptide 
hydrolysates into >50, 50-10, 5-10 kDa, and <5 kDa fractions and investigate bioactivity 
against breast cancer cells in vitro. 
 
Materials and Methodology 
Rice-bran. Heat stabilized de-fatted rice-bran (HDRB) was obtained from Riceland 
foods (Stuttgart, AR), the Romicon ultrafiltration system was purchased from Koch 
membrane systems (Massachusetts, USA), and the food-grade Alcalase enzyme derived 
from a bacterial strain purchased from Novozyme (North Carolina, USA). 
 
Cell lines. Human breast cancer cells, MCF-7 and HTB-26 cancer cell lines were 
purchased from ATCC (Manassas, Virginia, USA), Dulbecco’s modified Eagle’s 
medium, fetal bovine serum, gentamycin, penicillin, and streptomycin were purchased 
from Hyclone (Logan, UT, USA). MTT kit was purchased from ATCC (Manassas, 
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Virginia, USA). All other chemicals were purchased from Sigma-Aldrich Chem. Co. (St. 
Louis, MO, USA). 
 
Direct hydrolysis of HDRB to obtain protein hydrolysates. Based on a response 
surface method optimization design, HDRB (ground and sieved through 60 mesh) (1:8 
w/v in de-ionized water) was digested with 3.5 AU Alcalase (Anson units of enzyme) at 
pH 8.0 and heated at 50ºC for 60 min. After this, the enzyme was inactivated by heating 
at 85ºC for 3 min (Novo Industri, 1988). The hydrolysis mixture was centrifuged at 
3,000g for 15 min to obtain the hydrolysates in the supernatant. The supernatant was 
freeze-dried and stored at 4C until needed. 
 
Generating gastrointestinal (GI) juices resistant bran hydrolysates. It is essential that 
the peptides be resistant to the GI tract to impart uninhibited biological function and bio-
availability. Hence the bran hydrolysates were passed through a simulated gastric and 
intestinal solution.  
 
Treatment with simulated gastric juice. Five grams of freeze dried bran hydrolysate 
was dissolved in a simulated gastric juice and allowed to incubate at 37 °C with constant 
shaking. Simulated gastric juice contained Sodium chloride (0.2 g) and concentrated 
hydrochloric acid (0.7 mL) in 100mL of de-ionized water maintained at pH 2.0 and at 37 
°C. Purified enzyme pepsin (Sigma-Aldrich Corp. St. Louis, MO) (0.32 g) was added and 
stirred. After 120 min of incubation of bran hydrolysates in he gastric juice, pH was 
adjusted to 7.2 to inactivate the enzyme. The reaction mixture was centrifuged at 3,000 g 
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for 20 min to obtain soluble peptide hydrolysates in the supernatant. In the in vitro 
digestibility studies, the samples are typically examined up to 120 min. The resistant 
supernatant hydrolysate was freeze dried and stored at 4°C. 
 
Treatment with simulated intestinal juice. The simulated gastric juice treated 
hydrolysate (in freeze dried form) was dissolved in the simulated intestinal juice and 
allowed to incubate at 37 °C with constant shaking for 120 min. Simulated intestinal juice 
contained Potassium phosphate monobasic (0.68 g) and sodium hydroxide 0.2 N (7.7 
mL) in 100 mL de-ionized water maintained at pH 8.0 and at 37 °C. Pancreatin (Sigma-
Aldrich Corp. St. Louis, MO) at a final concentration of 0.1% was added and stirred. 
After 120 min (Takagi et al, 2003), enzyme was inactivated by heating at 85 oC for 10 
min. The reaction mixture was centrifuged at 3,000 g for 20 min to obtain soluble peptide 
hydrolysate in the supernatant. The GI resistant peptide hydrolysate was stored at 4°C. 
 
Fractionation of gastrointestinal resistant peptide hydrolysate by ultrafiltration. 
Fractionation of the GI resistant peptide hydrolysate was done to separate the peptides 
into fractions before testing for anti-cancer activity. A Romicon ultrafiltration system 
(Koch membrane systems, USA) equipped with 1" diameter hollow-fiber polysulfone 
membrane cartridges was used for this purpose. Membrane-cartridges having nominal 
molecular weight cut offs (MWCO) of 50,000 Da, 10,000 Da, and 5,000 Da were chosen 
for a sequential ultrafiltration procedure. The permeate collected after passing the GI 
resistant hydrolysate through 50kDa membrane was collected and passed through 10kDa 
membrane resulting in 3 fractions: >50kDa (retentate of first ultrafiltration step), 10-
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50kDa and <10kDa fractions (permeates). The <10kDa fraction was passed through 5kDa 
membrane to result in 2 fractions: 5-10kDa and <5kDa. The fractions were freeze-dried 
and stored at 4 0C until use for anti-cancer bioactivity. The GI-resistant bran fractions <5 
kDa and 5-10kDa were tested for inhibitory activity against human breast cancer cells 
MCF-7 and HTB-26 cancer cell lines.  
 
Human breast cancer cell culture and anti-cancer activity testing.   
Human breast epithelial MCF-7 cancer cells were cultured in Minimum essential medium 
(Eagle). For growth the following supplements were added: 2mM L-glutamine, Earle's 
BSS adjusted to contain 1.5g/L sodium bicarbonate, 0.1mM non-essential amino acids, 
1mM sodium pyruvate and 0.01mg/ml bovine insulin, 90%, fetal bovine serum, 10% and 
50ug/ml gentamycin. The cells were cultured at 37C in a humidified 5% CO2 incubator.  
Human breast (HTB-26) cancer cells were cultured separately at DMEM (Dulbecco’s 
Modified Eagles Medium) in the presence of 10% fetal bovine serum, supplemented with 
1 mM L-glutamine, sodium pyruvate, 1 mM sodium bicarbonate and 50 g/mL 
gentamycin. Cells were grown at 37°C in a humidified atmosphere of 5% carbon dioxide.  
 
Breast cancer cell viability evaluation with peptide fractions: Monolayers of MCF-7 
and HTB-22 cells were allowed to grow for 2-3 days at 37°C on 24 well flat bottom 
plates. The media were discarded; cells washed with saline and 100 µL of rice bran 
peptide fractions were added to the cultures. Separate wells for controls were allocated 
where for positive (inhibitor) control, genistein (anti-cancer compound) at 200 M in 
saline and for negative (viability) control, saline alone were added. After 24-48 h of 
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treatments the media were discarded, followed by trypsinization of cells (0.1% trypsin-
0.53mM ethylene diamine tetra acetic acid solution). The trypan blue dye (indicator of 
cell viability) in culture media were added to each well. The contents of each well were 
mixed and carefully aspirated to load onto haemocytometer chambers for counting the 
numbers of viable cells remaining after exposure of samples and controls.   
 
MTT assay. The MTT [3-(4,5-dimethyl thiazole-2-yl)]-2,5-diphenyl tetrazolium 
bromide] cell titer assay was performed on the fraction that showed best anti-cancer 
activity based on the dye exclusion assay. This assay serves as a confirmatory test in 
determining the anti-cancer activity of rice-bran peptide fraction towards MCF-7 and 
HTB-22 cells. After 1-2 day culture of MCF-7 and HTB-22 cells respectively in growth 
media, approximately 1,000 cells/suspension were added on to flat-bottom 96-well plates. 
The cells were allowed to attach and grow for 36 h. Old medium was replaced with fresh 
medium and samples of peptide fraction were added to the wells for determining the anti-
cancer effect. Concentration- and time-dependent pattern of inhibition was monitored. 
MTT dye was added after each time-point (12, 24, 36, 48h) followed by the termination 
of colored formazan product formed upon reaction of the MTT dye with the cells by a 
detergent solution. The readings were taken at 570 nm in a Tunable Versamax Microplate 
Reader (Molecular Devices, Sunnyvale, CA). For control, appropriate row or column of 
wells was left untreated at each time-point. As a separate experiment the dosage response 
of the best fraction that showed anti-cancer properties with both the exclusion assay and 
the titer based assay was done on HTB-22 cells starting from 50 to 650 µg/mL.  
 93 
Data analysis. Experimental data were analyzed using SigmaPlot statistical software 
(Systat Software, Inc., San Jose, CA) with sample means and standard errors of 
approximately 10%. 
 
Results and Discussion 
Generation of peptide hydrolysates from rice bran 
 Response surface design was used to optimize conditions for enzymatic hydrolysis of 
rice bran to obtain peptide hydrolysates. The design selected 3.5 AU enzyme 
concentration, pH 8.0, 50ºC temperature, and a 60 min digestion time for enzymatic 
hydrolysis to obtain peptide hydrolysates from rice bran (refer figure 1.1, chapter 1). For 
obtaining peptides from cereal proteins, enzymatic approach is preferred over the 
chemical method where extraction by enzymatic hydrolysis yielded substantial amounts 
of protein when preparing protein isolates (Tang et al, 2002); however, combination of 
several parameters for a substrate contribute to different types of biological activities 
(Wang, 2005). In this study HDRB was digested with food-grade proteolytic enzyme 
(Alcalase) to obtain peptide hydrolysates.  
 
MCF-7 and HTB-22 breast anti-cancer activity of GI resistant rice bran peptide 
hydrolysate fractions.  
Figure 2.1 depicts the effect of GI and non-GI resistant peptide fractions on MCF-7 cells. 
On MCF-7 cells GI-resistant peptide fractions of sizes <5 kDa were found to significantly 
inhibit the proliferation of viable cells compared to negative control and non-GI resistant 
fractions. Negative control was left untreated and was overlaid with saline, supposedly 
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exhibiting normal pattern of cell growth. There is approximately a three-fold reduction in 
viable cells as seen with GI-resistant <5kDa fraction compared to the (inhibitory) control. 
The positive (inhibitory) control used was genistein (soy isoflavone) at concentration of 
200 μM, an effective concentration for breast and other cancer cell inhibition. 
Anticarcinogenic soy protein components including Lunasin (peptide) (Galvez et al, 
2001) and a tridecapeptide (MITLAIPVNKPGR) (Maruyama et al, 2003) has been shown 
to inhibit either breast cancer cell growth or mammary tumor formation in mice. Since 
then identification of specific protein components from soy or any cereal source is 
lacking. Demonstration of <5kDa rice bran peptide fraction to cause breast cancers 
(MCF-7 and HTB-22) cell proliferation inhibition could be indicative of the presence of 
peptides in cereals like rice and soy to directly inhibit cancerous cell growth as well as 
tumor formation.  
 
In order to confirm the peptide-bioactivity experimental findings, a more specific assay, 
the MTS based titer assay was conducted. Figure 2.2 depicts MTS based cell titer assay 
results for confirming inhibitory actions of peptide fractions on breast cancer cells. This 
assay reflects cytotoxicity as an indication of early damage to cells thereby reducing 
metabolic (mitochondrial) activity. We find there is over 70% cytotoxicity to MCF-7 
cells with the <5 kDa fraction very similar to the inhibition pattern observed with the 
positive (inhibitory) control, while on HTB-22 cells the same fraction showed nearly 
80% inhibition. The 5-10 kDa fraction caused around nearly 60% cytotoxicity to MCF-7 
cells and only about 45% inhibition to the HTB-22 cells. The results of this test confirm 
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that resistant peptide fractions <5 kDa inhibit growth of breast cancer cells similar to the 
positive (inhibitory) control, a known anti-cancer agent.  
 
Figure 2.3 shows time- and dosage-dependent pattern of inhibition on HTB-22 cells by 
the <5kDa fraction. Results obtained from this experiment reveal that the fraction at 24 
and 48h time-points showed no inhibition compared to the untreated cells. However, at 
the 72 h time-point there was a significant inhibition in the growth of HTB-22 cells in a 
dose- as well as time-dependent manner (Figure 2.3). The HTB-22 cells showed 
maximum sensitivity at 650 µg/mL of <5 kDa fraction treatment with a 65% inhibition in 
the growth at 72 h time-point.  
 
The initial screening for determination of anti-cancer activity was done employing the 
trypan blue dye exclusion assay and confirmed using the MTS assay for anti-cancer 
properties of the fraction. The time- and concentration-dependent growth inhibition 
patterns observed with the <5kDa peptide fraction on HTB-26 suggests that the fraction 
could have a better and positive impact on reducing progression of human breast cancer. 
The <5kDa fraction showed a better inhibition on breast cancer cells. The dosage and 
time-dependent growth inhibition pattern may imply that the fractions may be a slow-
acting. Higher doses may reduce the time needed for killing the maximum number of 
cells. Amino acid make-up and the purity of these fractions can determine the extent of 
inhibitory activity. Isolation and purification of <5 kDa fraction peptide(s) that show 
similar or enhanced extent of anti-cancer activity may form the basis for fully 
characterizing the anti-cancer bran peptide. 
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Figure 2.1 Viability of MCF-7 cells after exposure to 
rice bran peptide fractions measured by Trypan blue 
dye exclusion assay 
 
Values are means trials ± SE. Values not connected by same letters are significantly different (P<0.05), 
Negative (viability control): saline; Positive (inhibitory control): Genistein (400µg/ml) . Peptide fractions 
1mg/ml 
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Figure 2.2. MTS confirmatory anti-cancer activities 
of rice bran peptide fractions on MCF-7 and HTB-22 
cells. 
Values are means of two trials ± SE. Values not connected by same letters are significantly different 
(P<0.05).  
MTS - (3-(4,5-dimethylthiazole-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
Negative (viability control): saline 
Positive (inhibitory control): Genistein (200µM). 
Peptide fractions 1mg/ml 
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Figure 2.3. Dosage response for anti-proliferative 
activity of bran peptide <5 kDa fraction with HTB-26 
cells. 
Values are means of three trials ± SE. Values not connected by same letters are significantly different 
(P<0.05), Negative (viability control): saline; Positive (inhibitory control): Genistein (400µg/ml).  
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CHAPTER 3 
 
Human Lung and Liver anti-cancer properties of peptides obtained from heat 
stabilized defatted rice bran by enzymatic hydrolysis.  
Kannan A, Hettiarachchy N, Johnson MG, Nannapaneni R. 
 
[Part of the chapter published in J Agric Food Chem. 2008 Dec 24;56(24):11643-7] 
Abstract 
 
Lung cancer is the number one cause of cancer deaths in the United States, while Liver 
cancer is the most common cancer type in developing countries. As an alternative 
treatment, to reduce the risk of developing cancer the focus is on identifying compounds 
present in natural foods that could bear lung ang liver anti-cancer properties. Studies on 
identifying specific components that could possibly contribute to anti-disease 
characteristics within rice-bran protein isolates or peptides are very minimal. With 
evidence from earlier work that low molecular sized fractions inhibit growth of colon and 
breast cancer cells, the objective was to test comprehensively, the same fractions for  
anti-cancer activity on other cancer cell lines as well. Lung (A-549) and Liver (HepG2) 
cancer cells were tested using trypan blue dye exclusion and MTS cell titer assays. GI-
resistant fractions were found to inhibit proliferation of viable cancer cells significantly 
compared to control and non-GI resistant fractions. MTS assay confirmed the anti-
proliferative effects of the GI-resistant fractions showing 60% cytotoxicity to A-549 cells 
with the <5 kDa fraction and the same fractions caused more than 80% cytotoxicity to 
HepG2 cells. The 5-10 kDa fraction caused approximately but caused nearly 80% 
cytotoxicity to HepG2 cancer cells. The results show that the resistant peptide fractions 
<5 kDa and 5-10kDa inhibit the growth of liver and lung cancer cells with pronounced 
activity on liver cancer cells. Our earlier studies on characterizing the <5kDa fraction for 
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the presence of bioactive pure peptide has validated the anti-cancer effects seen in this 
study against lung and liver cancer cells. Identification and characterization of bioactive 
peptides in the laboratory may generate the possibility of supplementing them into our 
diets for fighting against cancer or other diseases that have high mortality rates. 
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Introduction 
Lung cancer is the number one cause of cancer deaths in the United States. In the year 
2006, The American Cancer Society had predicted approximately 174,470 new cases of 
lung cancer (both small cell and non-small cell) and since then we find a slow decline in 
new incidence rate. Liver cancer is the most common cancer type in developing 
countries, less common (2% of cancer deaths) in United States, affecting twice as many 
men as women. The American Cancer Society has estimated 21,370 new cases in 2008 
with 18,410 liver-cancer related deaths in the United States in 2007 (American cancer 
society, 2008). Chemotherapy, radiotherapy and liver transplantation are the treatment 
options available for treating liver cancer. As alternative treatment, to reduce the risk of 
developing cancer focus is on identifying compounds present in natural foods that could 
bear anti-liver cancer properties.  
 
Numerous studies and research have documented the positive links between foods and 
food components to lung cancers (Mine and Shahidi, 2006). In spite of intense research 
and significant progress made in the treatment of cancers like lung and liver over the past 
two decades, most cancers are still difficult to cure and long-term prevention remains 
essential, particularly knowing that the time between initial cellular degeneration and 
clinical detection of a malignancy is about 10–15 years.  
 
Fruits and vegetables are primary food sources that possess properties that fight against 
lung cancer (Hocman G, 1989). Both alpha-carotene and beta-carotene are protective 
against liver cancer and lung cancer in cell culture and animal studies. Most isoflavones 
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are common anticancer agents in reducing the rate of lung cancer. These isoflavones are 
present in a wide variety of food products including soybeans, yams and chickpeas. Some 
plant seeds exhibit anti-proliferative properties, evident from a study that investigated the 
effects of methanolic extract of adlay seed on human lung cancer cell line (Hung et al, 
2003). Soy, lycopene, green tea, flaxseed, melatonin, conjugated linoleic acid are some of 
the nutraceutical agents proposed to reduce the risk of lung cancer (Lockwood, 2007).  
 
Proteins are also found to exert similar anti-cancerous and apoptotic roles. A multimeric 
form of alpha-lactalbumin was first observed to exhibit characteristic features of 
apoptosis in human lung cancer cell line (A-549). Other cell lines the same protein 
affected were a variety of epithelial cell lines (Caco-2, HT-29, NCI) kidney cell lines 
(Vero, GMK) and mouse cell lines (WEHI 164, B9). (Hakansson et al,1995).  
 
Fruits and vegetables, their parts have been documented as anticarcinogenic to liver 
cancer cells in vitro. Apple peels have been found to exhibit significant antiproliferative 
characteristics on HepG2 cancer cells. Antiproliferative effects with other varieties of 
apples have also been reported by Liu et al (2001). 
 
Although cereals like soy have been used to obtain protein hydrolysates to evaluate for 
anti-cancer activities, other cereal grains including rice and its components have not been 
investigated for bioactivities. In previous studies, it has been shown that whole rice-bran 
extracts possess anti-proliferative, anti-mutagenic as well as anti-oxidative properties 
(Nam et al., 2005). Such studies on identifying specific components that could possibly 
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contribute to anti-disease characteristics within rice-bran protein isolates or peptides are 
very minimal and have motivated research on comprehensively testing bran-peptide 
fractions on various cancer cell lines in culture. Thus, the objective of our studies is to 
prepare peptide hydrolysates from rice-bran using a food-grade proteolytic enzyme, 
conduct gastrointestinal (GI) treatment to the hydrolysates and fractionate the GI-resistant 
peptide hydrolysates into >50, 50-10, 5-10 kDa, and <5 kDa fractions and investigate 
bioactivity against lung and liver cancer cells in vitro. 
 
Materials and Methods 
Rice-bran. Heat stabilized de-fatted rice-bran (HDRB) obtained from Riceland foods 
(Stuttgart, AR), the Romicon ultrafiltration system was purchased from Koch membrane 
systems (Massachusetts, USA), and the Food-grade Alcalase enzyme from a bacterial 
strain purchased from Novozyme (North Carolina, USA). 
 
Cell lines. Human Lung (A-549) cancer and liver (HepG-2) epithelial cancer cell lines 
were purchased from ATCC, USA. Dulbecco’s modified Eagle’s medium, fetal bovine 
serum, gentamycin, penicillin, streptomycin were purchased from Hyclone, USA. MTT 
kit and McCoy’s SA medium were purchased from ATCC (Manasssas, VA). All other 
chemicals were purchased from Sigma-Aldrich Chem. Co. (St. Louis, MO, USA). 
 
Direct hydrolysis of HDRB to obtain protein hydrolysates.  
HDRB (ground and sieved through 60 mesh) (1:8 w/v in de-ionized water) was digested 
with 3.5 AU Alcalase (Anson units of enzyme) at pH 8.0 and hydrolyzed at 50ºC for 60 
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min based on a response surface method optimization design. The enzyme was 
inactivated (Novo Industri, 1988) and the resulting hydrolysate mixture centrifuged at 
3,000g for 15 min. The supernatant was freeze-dried and stored at 4C until further used.  
 
Generating gastrointestinal (GI) juices resistant bran hydrolysates.  
It is essential that the peptides be resistant to the GI tract to impart uninhibited biological 
function and bio-availability. Hence the bran hydrolysates were passed through a 
simulated gastric and intestinal solution.  
Simulated gastric juice was prepared as follows: To deionized water (90 mL) in a 
100 mL volumetric flask Sodium chloride (0.2 g) and concentrated hydrochloric acid (0.7 
mL) were added and stirred for 30 min. The final volume was made up to 100 mL with 
deionized water and transferred into a beaker. The pH was adjusted to 2.0. Purified 
enzyme pepsin from Sigma-Aldrich Corp. St. Louis, MO (0.32 g) was added and stirred. 
The temperature of the solution was maintained at 37 °C. Five grams of freeze dried 
hydrolysate were dissolved in the simulated gastric juice and allowed to incubate at 37 °C 
with constant shaking. After 120 min, pH was adjusted to 7.2 to inactivate the enzyme. 
The reaction mixture was centrifuged at 3,000 g for 20 min to obtain soluble peptide 
hydrolysates in the supernatant. In the in vitro digestibility studies, the samples are 
typically examined up to 120 min. The resistant supernatant hydrolysate was freeze dried 
and stored at 4°C. 
Treatment with simulated intestinal juice: Simulated intestinal juice was prepared 
as follows: To deionized water (90 mL) in a 100 mL volumetric flask Potassium 
phosphate monobasic (0.68 g) and sodium hydroxide 0.2 N (7.7 mL) were added and 
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stirred for 30 min. Final volume was made up to 100 mL and transferred into a beaker. 
The pH of the solution was adjusted to 8.0 and the mixture maintained at 37 °C. 
Pancreatin (Sigma-Aldrich Corp. St. Louis, MO) at a final concentration of 0.1% was 
added and stirred. The simulated gastric juice treated hydrolysate (in freeze dried form) 
was dissolved in the simulated intestinal juice and allowed to incubate at 37 °C with 
constant shaking. After 120 min, enzyme was inactivated by heating at 85 oC for 10 min. 
The reaction mixture was centrifuged at 3,000 g for 20 min to obtain soluble peptide 
hydrolysate in the supernatant. The hydrolysate was stored at 4°C. 
 
Fractionation of gastrointestinal resistant peptide hydrolysate by ultrafiltration. 
Fractionation was carried out with a Romicon ultrafiltration system (Koch membrane 
systems, USA) equipped with 1" diameter hollow-fiber polysulfone membrane cartridges. 
The filtered soluble gastrointestinal resistant peptide hydrolysate was run through 
sequential ultrafiltration columns with membrane-cartridges having nominal molecular 
weight cut offs (MWCO) of 50,000 Da, 10,000 Da, and 5,000 Da. The permeates of the 
first (50,000 Da) ultrafiltration (UF) and the second, dia-filtration step (DF) were pooled 
and subjected to the second run through the 10,000 Da and then 5,000 Da MWCOs 
respectively. The resulting retentates from each of the MWCO were freeze-dried and 
stored at 4 0C until use for anti-cancer bioactivity. The GI-resistant bran fraction <5 kDa 
was tested for inhibitory activity against human lung (A-549) and liver (HepG2) cancer 
cell lines. 
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Cancer cell culture and anti-cancer activity 
Human lung A-549 cancer cells were cultured in Ham's F12K medium with 2 mM L-
glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 90%; fetal bovine serum, 10% 
and 50ug/ml gentamycin at 37°C in a 5% CO2 incubator. Human liver epithelial cancer 
cell line HepG2 was cultured at 37C in DMEM (Dulbecco’s modified eagles medium) in 
the presence of 10% fetal bovine serum, supplemented with 1mM L-glutamine, Sodium 
pyruvate, 1mM Sodium bicarbonate and 50 g/mL gentamycin. After cell growth 
achieved 70%, cell viability was monitored employing the trypan blue dye exclusion 
assay after peptide treatments. Briefly, the monolayer was allowed to grow for 2-3 days 
at 37°C on 24 well flat bottom plates. 100 µL of rice bran peptide fractions at 1 mg/mL 
protein content were added on to the cultures. For positive control genistein at 200 and 
400 M in saline and for negative (viability) control saline alone was used. After 24-48 h 
of treatments the media were removed, and the cells briefly dissociated with 0.1% 
trypsin-0.53mM ethylene diamine tetra acetic acid (EDTA) solution. Following this 0.5% 
trypan blue dye mixed in growth medium was added on to each well. Samples were then 
aspirated from each well and loaded onto chambers in haemocytometer cell and cell 
counts were taken. This assay reflected the number of viable cells that survived after 
treatment with peptide samples.  
 
Cell proliferation inhibition was confirmed using the phenazine methosulfate 3-(4,5-
dimethyl thiazole-2-yl)]-2,5-diphenyl tetrazolium bromide (MTS) mix-based cell titer 
assay. After about 36 h of A-549 and HepG2 cell growth respectively, cells were 
trypsinized, loaded onto a hemocytometer and counted. Approximately 1000 cells per 
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well were used for growth onto 96 well flat bottom plates. The cells were allowed to 
attach and grow for 36 h. After 36 h old media were replaced with fresh media, and 
samples of bran peptide fractions were treated with the cells. After 2-4 h exposure of the 
rice bran peptides to the monolayer, the phenazine methosulfate 3-(4,5-dimethyl thiazole-
2-yl)]-2,5-diphenyl tetrazolium bromide (MTS) mix was added at a final volume of 
20 µL/100 µL medium and then incubated for an additional 60 min under the same 
conditions. The reaction was terminated by adding 10% SDS, and the absorbance of 
formazan measured at 490 nm. Positive (inhibitory) and negative (viability) controls were 
used similarly as used in the trypan blue dye exclusion assay. All assays were performed 
in duplicates and the results expressed as mean values ± standard error. 
Data Analysis. Experimental data were analyzed using JMP 7.0 statistical software with 
the least significant differences between samples being P <0.05. 
 
 
Results and Discussion 
Enzymatic hydrolysis of rice-bran by Alcalase enzyme The parameters for enzymatic 
hydrolysis [Alcalase concentrations (0.5, 3.5 and 10 Anson units), pHs (6, 8, 10), 
temperatures (40C, 50C, 60C) and incubation times for digestion (30 min, 60 min, 90 
min)] were previously used and optimized using RSM to obtain optimum peptide 
hydrolysates from HDRB (Kannan et al, 2008).  
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Lung and Liver anti-cancer activity evaluation of GI resistant peptide fractions 
Trypan blue dye exclusion assay was conducted to determine cell viability after treatment 
of cells with peptide fractions. This assay evaluates the number of viable cells that remain 
after exposure of peptides on to HepG2 as well as A-549 cells.  
 
Figure 3.1 depicts the effect of GI and non-GI resistant peptide fractions on A-549 cells. 
On A-549 cells GI-resistant peptide fractions <5 kDa and 5-10kDa were found to inhibit 
proliferation of viable cells significantly compared to negative control and their non-GI 
counterparts, although almost a two-fold inhibition was observed with 5-10kDa fraction. 
Figure 3.2 depicts the effect of GI and non-GI resistant peptide fractions on HepG-2 cells. 
On HepG-2 cells GI-resistant peptide fraction <5 kDa was alone shown to inhibit 
proliferation of viable cells significantly compared to non-GI resistant fraction and 
negative control. The positive (inhibitory) control used was genistein at concentration of 
200 μM. It is an isoflavone that is a known anti-cancer agent, able to arrest the growth of 
both lung and liver cancer cells in vitro. Other cereal extracts and protein hydrolysates 
have shown positive effect on the inhibition of both lung and breast cancer cell 
proliferation on cancer cells. However there have been very few studies that have tested 
pure components for their ability to suppress human cancer cell proliferation specific to 
each organ and particularly none that have been made GI-resistant.  
 
When the peptide fractions were tested for gastrointestinal resistance, resistant peptides 
were generated, which not only meant that they were exposed to highly specific 
enzymatic cleavage rendering them to expose more side chains but also may imply their 
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suitability in the digestive tract rendering absorptive and hence consumable properties. In 
our body peptides are usually generated when proteins pass through the intestine where 
gastrointestinal enzymes act and release the peptides before absorption. Depending upon 
the nature of the proteins, peptides and their amino acid sequences, these 
proteins/peptides may exert specific biological functions. Bioactive peptides when 
ingested should pass through the intestinal barrier and be transported to the target organs 
to impart antihypertensive or anticancer activities. Thus we support our experimental 
observations that gastrointestinal resistant peptide fractions (<5 kDa and 5-10 kDa) tend 
to open their chains up imparting more bioactivity by effectively inhibiting proliferation 
of both lung and liver cancer cells more than the non-resistant fractions. Moreover 
soluble peptides were only generated in a process of eliminating organic or other 
constituents of rice bran that could possibly interfere with bioactivity. We believe 
although rice bran has organic bioactive components, soluble peptides derived from 
enzymatic hydrolysis of protein hydrolysates can aid in inhibitory action of human anti-
lung and liver cancer cell proliferation, and can have true biological activity in terms of 
bioavailability and delivery.  
 
In order to confirm the peptide-bioactivity experimental findings, a more specific assay, 
the MTS based titer assay was conducted. Figure 3.3 depicts MTS based cell titer assay 
results for confirming inhibitory actions of peptide fractions on lung and liver cancer 
cells respectively. This assay reflects cytotoxicity as an indication of early damage to 
cells thereby reducing metabolic (mitochondrial) activity. We find there is over 60% 
cytotoxicity to A-549 cells with the <5 kDa fraction and the same fractions caused more 
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than 80% cytotoxicity to HepG2 cells. The 5-10 kDa fraction caused around 50% on A-
549 but caused nearly 80% cytotoxicity to HepG2 cancer cells. The results of this test 
confirm that resistant peptide fractions <5 kDa and 5-10kDa inhibit growth of liver 
cancer cells more effectively than on lung cancer cells. 
 
The findings reported from this study could form a basis for animal and human trials to 
determine the toxicity and confirmatory nature of these bioactive rice bran peptide 
fractions. Our earlier studies on characterizing the <5kDa fraction for the presence of 
bioactive pure peptide has validated the anti-cancer effects seen in this study against lung 
and liver cancer cells. Identification and characterization of bioactive peptides in the 
laboratory may generate the possibility of supplementing them into our diets for fighting 
against cancer or other diseases that have high mortality rates. 
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Figure 3.1. Viability of A-549 cells after exposure to 
rice bran peptide fractions measured by Trypan blue 
dye exclusion assay 
Values are means of two trials ± SE. Values not connected by same letters are significantly 
different (P<0.05) 
neg control: saline 
pos control: Genistein (200µM)  
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Figure 3.2. Viability of HepG2 cells after exposure to 
rice bran peptide fractions measured by Trypan blue 
dye exclusion assay 
 
Values are means trials ± SE. Values not connected by same letters are significantly different (P<0.05), 
Negative (viability control): saline; Positive (inhibitory control): Genistein (400µg/ml) . Peptide fractions 
1mg/ml 
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Figure 3.3. MTS confirmatory anti-cancer activities 
of rice bran peptide fractions on A-549 cells and 
HepG2 cells.  
 
Values are means trials ± SE. Values not connected by same letters are significantly different (P<0.05), 
MTS - (3-(4,5-dimethylthiazole-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
Negative (viability control): saline; 
 Positive (inhibitory control): Genistein (400µg/ml)  
Peptide fractions 1mg/ml 
 
 
 
 
 
 
 
 
 
 
a a a 
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CHAPTER 4 
Purification and characterization from promising anti-cancer peptide fraction, 
amino acid analysis and sequencing. 
 
Abstract 
Specific peptide sequences with specific amino acids sequences are thought to be 
modulators of biological function. Characterization generally involves separation, 
purification, and detection of structural components of the peptide or protein under 
investigation. This will enable bioactive peptides to act as functional foods that can slow 
disease progressions. Based on earlier findings that rice bran peptide fractions have the 
ability to cause growth arrest in colon breast lung and liver cancer cell types in vitro, the 
<5kDa fraction originally separated by pressure-driven membrane based separation 
(ultrafiltration) that showed significant anti-cancer effects was subjected to further 
characterization to yield pure peptide(s) that show similar or enhanced anti-cancer 
properties. Purification by ion exchange followed by reverse phase HPLC was done to 
obtain single pure peptide(s) from the 5kDa fraction. 50mM Sodium Chloride elutae from 
ion exchange column caused appoximately 75% inhibition to colon and liver cancer cells 
growth and, 60% and 68% inhibitory activities on lung and breast cancer cells 
respectively. The eluate was purified using HPLC using peptide-specific column. It was 
observed that the 60-70 minute peak showed enhanced anti-cancer activity, namely. 84% 
inhibition on colon, 80% on breast and 84% on liver cancer cells. Accurate molecular 
mass of the pure peptide by MALDI-TOF revealed a mass of 685.378 Da. Amino acid 
analysis revealed the presence of Glutamic acid, Proline and Arginine. Tandem mass 
spectrometry for determining the amino acid sequence of the pure peptide(s) was done 
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using post-source decay fragmentation analysis. The sequence of the pure peptide read 
Glu-Gln-Arg-Pro-Arg (EQRPR).  
Thus a pure multiple-site anti-cancer pentapeptide was isolated and characterized 
from rice bran. 
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Introduction  
Specific peptide sequences with specific amino acids sequences are thought to be 
modulators of biological function. Several bioactive peptides have been characterized 
fully from food proteins using a systematic approach involving several steps and 
methods. Characterization generally involves separation, purification, and detection of 
structural components of the peptide or protein under investigation. Separation of 
bioactive peptides from enzymatic hydrolysates provides scope to create functional foods 
that can slow disease progressions. A number of food-derived bioactive (antioxidative) 
peptides, usually composed of 3 to 16 amino acid residues, have been isolated from these 
hydrolysates. Among these peptides, some contained hydrophobic amino acids (Val or 
Leu) at the N-terminus, Pro, His, or Tyr and in sequences containing mainly acidic acid 
residues (Glu, Asp) (Saiga et al., 2003). 
Proper analytical separation and purification techniques can identify specific 
amino acid sequences, and hence peptides as important biological modulators. A number 
of separation techniques are available. There are pressure-driven membrane based 
separation techniques like microflitration, ultrafiltration, nanofiltration, and reverse 
osmosis. Soy protein hydrolysates were fractionated using ultrafiltration membranes 
where the effect of membrane pore sizes on the molecular size distribution as well as 
functional properties of the protein hydrolysate were studied (Deeslie and Cherian, 2006). 
Ultrafiltration has also been used to obtain bioactive peptides from soy for ACE-1 
inhibitory activity (Cha and Park, 2005). β-lactoglobulin from whey was isolated using 
ultrafiltration membrane enzymic reactor where the authors were able to retain β-
lactoglobulin in the reactor while peptides generated from hydrolysis of α-lactalbumin 
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and serum albumin permeated through the membrane (Sannier et al, 2000). Peptides 
identified in milk as a result of proteolysis after ultrafiltration ranged in sizes from 1023 
to 2000 daltons (Wedholm et al, 2008). 
As the subsequent stage in characterization, purity becomes an important criterion 
to concentrate all of the bioactivity within a pure compound. Purification of peptides 
ideally requires preparative mode of chromatography that relies on ion exchange, 
hydrophobic interaction, size exclusion, or affinity. These are generally employed as 
initial purification steps where the peptides of interest are isolated out from a given pool 
that had exhibited bioactivity as a whole fraction. Following this, reverse phase HPLC 
has been widely employed with or without coupling to ion-exchange chromatography for 
efficient purification of the peptide of interest (Le´onil et al, 2000).  Prakash et al (2002) 
prepared protein hydrolysates prepared from rice bran employing size exclusion 
chromatography coupled with HPLC. The molecular fragments ranged between 1 and 
150 kDa after hydrolysis with alcalase and flavourzyme. Adipogenesis inhibitory peptide 
was isolated and purified from black soybean (Rhynchosia volubilis Lour.) hydrolysate 
using systematic approach of separation by ultrafiltration with 3 and 10 kDa cutoffs 
MWCO, gel filtration chromatography (Superdex Peptide 10/300 GL column), and 
reverse-phase high-performance liquid chromatography (C18 column). The peptide was 
identified as Ile-Gln-Asn (Kim et al, 2007). 
To assess purity and further characterize the structural components within the 
bioactive peptide, various proteomic tools can be used. Several food peptides have been 
characterized using Mass spectrometry (MS), a versatile tool not only for determining 
accurate molecular sizes but also for providing structural information of the pure 
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compound.  MS is by far the most informative technique for determining the purity of 
protein/peptide samples. The mass spectrum provides the number of components present 
and an indication about the length of the proteins/peptides. It has been widely used as a 
modern tool to characterize peptides and proteins present in foods that can impart 
bioactive properties. MS in conjunction with database searching plays an increasingly 
important role in the characterization of peptides. Of the ionization modes, Matrix 
assisted laser desorption ionization (MALDI) has made it possible to not only determine 
the accurate mass of peptides obtained in a hydrolysate of food proteins but also is able to 
identify the purity of a pure protein or peptide, determine its fragmenting patterns and 
also determine the de novo sequence of the amino acids.  
The shorter the peptides the more accurate will be the prediction by MS-MALDI 
of the sequence, nevertheless the score for predicting the best hit for sequences present in 
longer peptides can enable identification of C-terminal amino acids to a reasonable 
accuracy. Although MS was applied more popularly to biologically important peptides, 
its use is growing in food peptide characterization as well. Characterization of dairy 
products, proteins and peptides in fish, legumes and cereals, cheese, and milk proteins 
have become possible using MS. Lunasin, an anti-cancer peptide purified from soybean 
seeds was characterized using MALDI peptide mass mapping (Jeong et al, 2003).  The 
identity of lunasin was established by comparison of the peptide mass map of the putative 
peptide obtained from in-gel tryptic digest with predicted masses of lunasin cleaved by 
trypsin (Shevchenko et al, 1996).  
Precise characterization of peptides hence becomes a valuable tool in ascribing 
each peptide to its bio-functional role. Because peptides fragment in a sequence specific 
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way, the original amino acid sequence can be derived from the fragment ion signals. Post 
source decay (PSD) has been used successfully to obtain amino acid sequence 
information for many peptides (Spengler et al, 1997). 
In this context and based on the findings that rice bran peptide fractions have the 
ability to cause growth arrest in certain cancer cell type proliferation, the <5 kDa fraction 
originally separated by pressure-driven membrane based separation (ultrafiltration) that 
showed significant anti-cancer effects was subjected to further characterization to yield 
pure peptide(s) that show similar or enhanced anti-cancer properties. Hence the 
objectives were to subject the <5 kDa peptide fraction to ion exchange and HPLC 
purification to obtain single pure peptide(s). This was followed by evaluation of single 
pure peptides for similar or enhanced anti-cancer activity to that of the <5 kDa fraction. 
The pure peptide that showed anti-cancer activity was subjected to mass spectrometry 
analysis for determining the accurate molecular mass, amino acid analysis and tandem 
mass spectrometry for determining the amino acid sequence of the pure peptide(s). 
 
Materials and Methods 
Hp 1090 series, HPLC system, reverse-phase C-18 peptide column, analytical grade, 
sephadex G-75 resin from Pharmacia biotech AB, Uppsala Sweden, biopore C18 
preparative HPLC column, amino acid analyzer from Beckman Coulter, Bruker Reflex 
III (Bruker Daltonics GMBH, Bremen, Germany) and Bruker Ultraflex II time-of-flight 
mass spectrometers at the Statewide mass spectrometry facility, University of Arkansas. 
All other chemicals purchased were of HPLC grade and purchased from Sigma, MO, 
USA. 
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Methods 
Ion exchange chromatography 
A sephadex G-75 ion exchange resin was packed into a glass column and equilibrated 
with 10mM phosphate buffer, pH 8.0. 10mL of < 5kDa peptide hydrolysate (~1mg/mL 
protein concentration) was loaded onto the column at 1mL/min flow rate. The elution was 
started by washing the unbound hydrolysate eluted with 10mM phosphate buffer till 
about 5 bed volumes. After washing, the hydrolysate was eluted using 10mM phosphate 
buffer containing 50mM NaCl followed by elution with 10mM phosphate buffer 
containing 100mM NaCl for a total 5 bed volumes. The eluates were collected, 
concentrated in an Amicon concentrator with buffer exchange and stored at 4°C until 
used for anti-cancer activity determination. The anti-cancer activity of the eluates 
obtained after ion-exchange was determined using the MTS as described in earlier 
chapters. 
Preparative HPLC purification of IEC eluate showing anti-cancer activity 
Preparative scale peptide-specific column (Biopore Prep ID 22 x L 250 mm part # 34955) 
was used to separate peptides from the IEC eluates that showed better anti-cancer activity  
and the absorbance of the eluate monitored at 215nm. The gradient from solvent A 
(1.2mlTFA/1000ml deionized water) to solvent B (0.1%TFA in Acetonitrile:water 50:50) 
was varied from 100% solvent A to 100% solvent B over 80 minutes at 2ml/min flow rate 
monitored at 215nm. The peaks were collected and tested for anti-cancer activity, and the 
peak that showed anti-cancer activity was fully characterized using mass spectrometry, amino 
acid analysis and sequencing. 
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Amino acid analysis 
A modified method of AOAC 982.30a (1990) was used for hydrolyzing purified peptides. 
10mg of peptide samples were hydrolyzed in 10mL of 6.0 N HCl under vacuum at 150C 
for 12 h and evaporated under nitrogen at 60C. Sodium diluent buffer pH 2.2 (1 mL) 
was added to the dried peptide, filtered and the filtrate was analyzed for amino acids. The 
peptides were pretreated with performic acid prior to hydrolysis to preserve cysteine and 
methionine, while alkali hydrolysis was conducted to determine tryptophan (AOAC 
982.15, 2000). Amino acid analysis of the filtrate was conducted on an automated amino 
acid analyzer (Beckman 6300, Beckman Instruments, Inc. Palo Alto, CA) at a flow rate 
of 0.67mL/min (0.44 mL/min for buffer solutions and 0.23 mL/min for ninhydrin 
solution). Sodium citrate buffers (pH 3.3, 4.3 and 6.3) were used as eluents. The amino 
acid contents (in g/100g sample) were quantified by comparing them with amino acid 
profiles from external amino acid standards as follows (Peak sample/Peak standard) x 
Concentration standard x MW standard 
Mass spectrometry characterization of pure peptide 
For preliminary intact mass determination, 1.0 l of the HPLC purified peptide was 
mixed with 1.0 l saturated HCCA and spotted on Bruker MTP 384 ground stainless steel 
MALDI target. MALDI-TOF (time of flight) mass spectra were acquired on a Bruker 
Reflex III (Bruker Daltonics GMBH, Bremen, Germany) and Bruker Ultraflex II time-of-
flight mass spectrometers operated in the positive-ion reflectron mode.  High resolution 
exact mass of the same peptide was obtained by using MALDI Ionspec 9.4 T ion 
cyclotron resonance (ICR) mass spectrometer. For the exact mass measurements 2, 5 
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dihydrobenzoic acid (DHB) was used as the MALDI matrix and followed exactly the 
same spotting technique.  
 
MALDI fragmentation 
Fragmentation of intact peptide ions were performed to obtain sequence information 
using MALDI post source decay studies. MALDI-PSD fragmentation of these ions were 
analyzed using the “Lift” mode in Bruker Ultraflex II (Bruker Daltonics GMBH, Bremen, 
Germany) time-of-flight/ time-of-flight mass spectrometer (TOF/TOF MS).  
Data analysis and de novo sequencing 
Fragmentation pattern obtained by MALDI-TOF-TOF was interpreted using Bruker 
Biotools software, which uses de novo sequencing algorithm to determine the best 
sequence for the observed fragmentation pattern.   
 
RESULTS AND DISCUSSION 
 
Ion exchange chromatography and anti-cancer activity of eluates: The <5 kDa fraction 
was subjected first to ion exchange chromatography and the peaks were eluted using 50mM 
and 100mM NaCl. On colon and liver cancer cells the 50mM NaCl eluate showed around 
75% inhibition by the MTS dye assay. On breast cancer cells there was 68% inhibition while 
on lung cancer cells there was 60% inhibition (Figure 4.1). While the 50mM eluate showed 
cancer cell inhibitions better than the 100mM eluates, the 50mM eluate possibly had the pool 
of <5kDa peptides that contribute towards the anti-cancer effect. Ion exchange 
chromatography was the most popular tool used especially to separate peptides from protein 
hydrolysates in the past decade. With the advent of sophisticated purification techniques 
involving reverse phase HPLC, LC-MS and specific columns, the need for fully 
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characterizing a pure peptide has become imminent following just ion exchange purification. 
Moreover bioactive peptides separated out in ion exchange columns have been subjected to 
an additional reverse phase HPLC step to get pure peptides amenable for mass spectrometry 
and sequence studies. Hence the 50mM IEC eluate was subjected to HPLC purification using 
a peptide-specific column.    
 
Reverse phase HPLC purification 
 The 50mM IEC eluate was subjected to HPLC in a preparative HPLC with a peptide-specific 
wide bore column (ID 22 x L 250 mm). The gradient from solvent A (1.2mlTFA/1000ml 
deionized water) to solvent B (0.1%TFA in Acetonitrile:water 50:50) was varied from 
100% solvent A to 100% solvent B over 80 minutes at 2ml/min flow rate monitored at 
215nm.Figure 4.2 shows the HPLC profile of 50mM IEC eluates. The peaks were collected 
at 10 min intervals and tested for anti-cancer activity. It was found that the 60-70min fraction 
showed anti-cancer activity and this fraction was further purified in HPLC. Figure 4.3 shows 
the purification of a single peptide obtained from 60-70min fraction isolated from ion 
exchange chromatography. The peak eluted at 62 min was evaluated for anti-cancer activity.  
Reverse phase HPLC has been the most preferred tool for purification of the peptide of 
interest from the extracts or from the ion exchange eluates. Several peptides from food 
sources have been isolated to purity using this technique where a mixture of solvents, 
usually acetonitrile and water with ion pairing reagents like trifluoroacetic acid aids in 
formation of a polar to non-polar gradient. The extracts when injected into a specific 
column get separated out with the programmed gradient thereby separating and 
identifying polar, nonpolar, hydrophobic peptides. The 62 min eluate of the peptide 
suggests the presence of both polar and non-polar amino acids that make up the peptide.  
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Anti-cancer activity of pure peptide  
The pure peptide showed 84% inhibition on colon cancer cells, 80% on breast cancer 
cells and 84% on liver cancer cells, very similar to the positive (inhibitory) control 
(genistein) at 400g/ml. On breast and liver cancer cells the pure peptide showed 80% 
and 85% inhibitions respectively, while on lung cancer cells there was 69% inhibition 
(Figure 4.4). The results show that the peptide bears strong anti-cancer activities better 
than the <5kDa peptide fraction from which it was purified. It is conclusive to observe 
that purification of a single peptide from the <5kDa rice bran hydrolysate resulted in 
identifying the anti-cancer component within rice bran. When its activity is tested and 
compared against all cancer types, we do not find enhanced activity of the peptide 
towards lung cancer cells. More specific lung cancer types like small cell, squamous cell, 
and non-small cell lung cancer carcinomas may need to be tested with the peptide to look 
for better inhibition of proliferation. 
Amino acid analysis Amino acid analysis revealed the predominance of 4 amino acids 
suggesting the anti-cancer peptide could be a short peptide. The amino acids identified 
were arginine, proline, glutamic acid, and glutamine (Table 4.1). The activity of 
biofunctional peptides is based on their inherent amino acid composition and sequence. 
The size of active sequences may vary from two to twenty amino acid residues, and many 
peptides are known to have multifunctional properties (Meisel and FitzGerald, 2003). 
Here we find the possibility of a tetra to penta peptide bearing anti-cancer properties 
against several types of cancer cell lines. Other studies have also produced short peptides 
possessing biological activities like immunomodulatory, ACE-inhibitory, and anti-
oxidative properties (Migliore-Samour et al, 1988, Suetsuna et al, 2000). The peptides 
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range from di-, tri- to penta-peptides like Ile-Ile-Ala-Glu-Lys (Nagaoka et al 2001) 
isolated from -lactoglobulin by tryptic hydrolysis. The shorter the peptide chains the 
more accessibility would exist for solvents and exposure of functional groups to impart 
functional properties. Moreover presence of proline signifies more accessibility to solvent 
owing to its predominance in turns of a polypeptide chain. It also has a rigid 
conformation than most other amino acids. Occurrences of proline residue in bioactive 
peptides are not uncommon and are also thought to be a major player to contribute to 
bioactivity of the peptide   
Dose-response pattern of the pure peptide (Figure 4.5) revealed that from 600µg/mL to 
1000 µg/mL maximum inhibition was achieved on most cancer cells even at 24 hour 
period. There is an increase in inhibition pattern as the dosage increases and seems to 
plateau off beyond 600µg/mL. The dosage for the pure peptide is similar to what was 
observed with the 5kDa fraction on most cancer cell lines as per the earlier studies except 
there is a 24 h response for significant anti-cancer activity.  
MALDI characterization of peptide 
Matrix assisted laser desorption ionization time of flight mass spectrometry (MALDI-
TOF-MS) analysis was performed on the HPLC purified peptide. Figure 4.6 shows the 
MALDI-TOF-MS spectrum of the purified fraction and confirms the purity of the 
fraction.  The accuracy of the mass was confirmed by MALDI-ICR (ion cyclotron 
resonance) -MS where the mass of the ion was measured to 10 ppm accuracy. By means 
of MALDI–TOF MS, single protonated molecular ions (M+H+) of the intact peptide were 
located at m/z 685.378 suggesting the possibility of a penta-peptide.  
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Further tandem (MS-MS) was performed on the predominant peak by isolating 
the ion inside the mass spectrometer to enable post source decay (PSD) fragmentation to 
obtain amino acid sequence (Figure 4.7). Three amino acids were identified from the C-
terminus end as Arg-Pro-Arg. The N-terminal amino acids when matched against the 
database showed a high prediction of Glu-Gln amino acids in the N-terminus end (Table 
4.2). The de novo sequencing thus revealed the peptide to have the amino acid sequence 
as Glu-Gln-Arg-Pro-Arg (EQRPR). The presence of charged (glutamic acid) and 
heterocyclic amino acid (proline) in the sequence could have attributed anti-cancer 
properties to the peptide. Low molecular sized bioactive peptides as tri- and penta-
peptides have been isolated and purified from soy protein and wheat germ respectively 
(Korhonen et al, 2003). The sequences for these peptides were Ile-Val-Tyr, and Leu-Leu-
Pro-His-His.  
All MS/MS spectra of peptides contain fragment ions, which result either from 
single cleavages of peptide backbone bonds and multiple cleavages. The extraction of 
sequence information from MS/MS spectra or fragment ion spectra without any prior 
knowledge about the sequence, i.e., de novo sequencing, allows elucidating the structure 
and sequence of a particular peptide. Such peptide sequences can then be used to identify 
a protein solely by homology searches such as BLAST Biotools that uses a scoring 
method to sort the most probable sequence.  
Fully characterizing a pure peptide, thereby identifying its structural components 
confirms the peptide to its identity, and enhanced bioactivity. This suggests and confirms 
the finding that an anti-cancer peptide has been isolated and purified from rice bran after 
enzymatic hydrolysis.  
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Figure 4.1 MTS anti-cancer activities on IEC eluted 
fractions.  
 
100mM: 100mM NaCl eluate; 50 mM: 50mM NaCl eluate 
Values are means trials ± SE. Values not connected by same letters are significantly different (P<0.05),  
Negative (viability control): saline; Positive (inhibitory control): Genistein (400µg/ml) .  
MTS - (3-(4,5-dimethylthiazole-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
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Figure 4.2 HPLC profile of 50mM IEC eluate.  
 
50mM NaCl eluate from ion exchange chromatography (IEC) subjected to HPLC. Peaks 
were collected every 10 min of the run and analyzed for anti-cancer activity. 60-70min 
peak (arrowhead) showed anti-cancer activity, which was further purified. 
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Figure 4.3 HPLC purification of single peptide from 
60-70min fraction from IEC.  
 
 62min peak (arrowhead) was collected for evaluation of anti-cancer effect. 
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Figure 4.4 MTS anti-cancer activities of pure peptide.  
 
Values are means trials ± SE. Values not connected by same letters are significantly different (P<0.05), 
MTS - (3-(4,5-dimethylthiazole-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
Negative (viability control): saline 
Positive (inhibitory control): Genistein (400µg/ml) 
Peptide fractions 1mg/ml 
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                  Figure 4.5: Dose response at 24h of pure 
peptide on cancer cells  
 
Values are means trials ± SE. Values not connected by same letters are significantly different (P<0.05), 
MTS - (3-(4,5-dimethylthiazole-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
Negative (viability control): saline 
Positive (inhibitory control): Genistein (400µg/ml) 
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Figure 4.6 MALDI profile of the pure peptide 
obtained after HPLC purification.  
 
x-axis: mass to charge ratio (m/z); y-axis: intensity 
Molecular mass of the peptide identified to be 685.378 daltons. 
Inset: Purified peak at 62min elution from HPLC. 
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Table 4.1. Amino acid analysis of the pure peptide 
obtained after HPLC purification 
 
Sequence of the peptide: Glu-Gln-Arg-Pro-Arg           
(EQRPR) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amino acids Peptide nmol/ml
Glutamic Acid 1.50
Proline                          0.99
Arginine                         2.65
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Figure 4.7: Tandem MS-MS PSD fragmentation of 
peptide 685.37 Da 
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Table 4.2. de novo sequencing of peptide matched for 
probable sequence based on exact mass of 685.378 Da 
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Conclusion 
 
 
This study has provided the basis for developing novel gastrointestinal 
environment resistant bioactive peptides active against different cancer cell types from 
heat-stabilized de-fatted rice bran (HDRB)., an underutilized and inexpensive co-product 
of rough rice processing.  
 HDRB can be a good starting material for creating new bioactive peptides that 
can be active against several chronic disease conditions. Owing to difficulty in protein 
extraction from bran, use of food-grade enzymes is preferred to directly hydrolyze bran 
protein to obtain peptides. Evaluating peptides’ resistances to gastrointestinal juices, 
fractionating and testing for anti-cancer activities on multiple-cancer sites formed a novel 
aspect of this research. Although lower molecular weight fractions and a five-amino acid 
peptide exhibited significant anti-cancer properties, it would be interesting to evaluate the 
possibility of peptides from higher molecular weight fractions that show substantial 
activity. 
A pure pentapeptide was isolated and fully characterized with the help of 
proteomic tools. Information obtained from characterizing structural components of the 
pentapeptide can be used to chemically synthesize the anticancer peptide for food 
ingredient or pharmaceutical use.   
 
